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ABSTRACT 
JIN HYANG KIM: The role of BCR destabilization in antigen processing 
(Under the direction of Barbara Vilen) 
 
The B cell antigen receptor (BCR) relays extracellular signals and delivers antigen to the 
endocytic compartment for processing and presentation.  Concurrently, BCR ligation 
destabilizes Ig-α/Ig-β from μ-heavy chain (μm).  Here, we describe that receptor 
destabilization represents a physical separation of μm from Ig-α/Ig-β.  Sucrose gradient 
fractionation localized Ig-α/Ig-β to GM1-containing lipid microdomains in the absence of 
μm.  Confocal and transmission electron microscopy studies revealed colocalization of 
unsheathed μm with clathrin-coated vesicles (CCVs).  Further, μm failed to associate 
with CCVs when receptor destabilization was inhibited, suggesting that unsheathing of 
μm is required for clathrin-mediated endocytosis.  In summary, we found that antigen 
stimulation physically separates Ig-α/Ig-β from μm, facilitating concomitant signal 
transduction and antigen delivery to the endocytic compartment.  In addition, we 
demonstrate the molecular basis and the role of BCR destabilization in antigen processing. 
Dissociation of Ig-α/Ig-β from μm requires tyrosine-587 (Y587) of the μm 
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transmembrane domain.  Receptors expressing an Y587F mutation transduced signals 
that were comparable to wild type receptors, yet failed to dissociate μm from Ig-α/Ig-β. 
Further, receptors harboring the Y587F mutation failed to associate with CCVs, resulting 
in diminished antigen in the lysosome-associated membrane protein-1 positive (LAMP-
1+) compartments and impaired antigen presentation.  Thus, the transmembrane tyrosine 
of μm mediates destabilization of the BCR complex and the association of antigen with 
CCVs.  Our data also indicate that association of receptors with CCVs is required for 
antigen presentation.  Together, we demonstrate that BCR destabilization reveals a novel 
and prerequisite step prior to the targeting of antigen into the endocytic pathway. 
 iii
DEDICATION 




I would like to thank my advisor Dr. Barbara Vilen for her excellent mentorship 
throughout my graduate study. I admire her passion and ability in training and teaching 
graduate students to be professional scientists. Specifically, I consider her training in 
rigorous thinking, critical interpretation and evaluation of scientific data to be a valuable 
lesson that I will continue to develop throughout my scientific career. I would also like to 
thank my committee members Dr. Jeffrey Frelinger, Stephen Clarke, Jack Griffith, and 
JoAnn Trejo for their encouragement and guidance throughout my project. I especially 
thank Dr. Jack Griffith and Dr. Alexandr Makhov of the UNC-CH TEM core facility for 
their continuous support throughout my TEM study. I acknowledge Dr. Tony Purdue of 
the TEM facility at the UNC-CH Biology department for allowing me to use the electron 
microscope and for his technical expertise in TEM. I also thank Dr. Lorraine Cramer for 
her effort to establish the TEM technique in our lab and for her training. Lastly, I would 
like to thank our lab members, Dr. Michelle Kilmon, Jennifer Rutan, Mileka Gilbert, 
Diane Carnathan, and Nikki Wagner for their constant support, feedback, and most 
importantly, for their friendship.  
 v
TABLE OF CONTENTS 
LIST OF TABLES………………………………………………………………………viii 
LIST OF FIGURES……………………………………………………………………….ix 
LIST OF ABBREVIATIONS…………………..…………………………………………xi 
 
Chapter 
I. Introduction and background……………..…………………………………..1 
1.1. Role of the BCR during development and humoral immune response………..1 
1.2. Structure and surface expression of the BCR complex………………………..1 
1.3. BCR-mediated signal transduction…………………………………………….6 
1.4. BCR-mediated antigen processing and presentation…………………………..9 
1.5. Endocytic motif……………………………………………………………….11 
1.6. BCR-mediated signals regulate trafficking of receptor-antigen  
complexes through the endocytic pathway…………………………………...13 
1.7. Early events in BCR-mediated antigen endocytosis………………………….14 
1.8. BCR desensitization and destabilization……………………………………...15 
1.9. Role of BCR destabilization in maintaining tolerance……………………….17 
II. Biophysical nature of BCR destabilization………………..………………...19
 vi
(Independent trafficking of Ig-α/Ig-β and μm is facilitated by the dissociation 
of the BCR complex) 
Introduction………………………………………………………………………..20 
Materials and Methods…………………………………………………………….22 
Results……………………………………………………………………………..26 
Discussion…………………………………………………………………………52 
III. The role of BCR destabilization in antigen processing……………..…..…...63 
(The transmembrane tyrosine of μ-heavy chain is required for BCR 
destabilization and entry of antigen into clathrin-coated vesicles) 
Introduction…………………...…………………………………………………..64 
   Materials and Methods………………………………………………………...….66 
Results……………………………………………...……………………………..69 





LIST OF TABLES 
 
Table                                       Page 
1. Assessment of subcellular localization of μm and Ig-α  
on native membrane sheets in M12g3r cells…………………………………………..40 
 
2. Assessment of subcellular localization of μm, Ig-α 
and CCVs on native membrane sheets in M12g3r cells………………………………46 
 
3. Assessment of subcellular localization of μm and Ig-α 
and on native membrane sheets in A20WT and A20Y/F cells………………………..74 
 
4. Assessment of subcellular localization of μm and CCVs 
on native membrane sheets in A20WT and A20Y/F cells………………………….. ..81 
 
 viii
LIST OF FIGURES 
 
Figure                                    page 
Chapter II 
2.1. Antigen stimulation induces BCR destabilization in K46μ cells.………………...27 
 
2.2. Destabilized Ig-α/Ig-β resides in lipid microdomains 
in the absence of μm ……….…………………………………………………….28 
 
2.3. M12g3r cells fail to express surface Ig-α/Ig-β 
in the absence of transfected μm……………..…………………………………..31 
 
2.4. Herbimycin inhibits BCR destabilization in M12g3r cells….....…………………32 
 
2.5. Herbimycin inhibits BCR-mediated signal transduction…………………………33 
 
2.6. Ig-β fails to cocap with μm following antigen stimulation………………………34 
 
2.7. Gold-conjugated PC10BSA induces tyrosine phosphorylation…………………...37 
  
2.8. Antigen stimulation induces a physical 
dissociation of μm from Ig-α/Ig-β…………..……………………………………38 
 
2.9. Antigen stimulation colocalizes mm with CCVs…………………………………43 
    
2.10. BCR ligation induced the association of antigen-μm, 
but not Ig-α with CCVs…………………………………………………………..44 
 
 2.11. BCR destabilization facilitate the translocation  
of antigen-bound μm to CCVs……………………………………………………50 
 
2.12. Two scenarios for antigen-induced movement  
of the BCR to the endocytic pathway……………………………………………….55 
 
 ix
 2.13. Lipid rafts do not colocalize with CCVs………………………………………..56 
 
 2.14. Antigen stimulation fails to induce the aggregation  




3.1. Surface expression level of human IgM in A20 cells…………………………….67 
 
3.2. Mutation of the transmembrane tyrosine of μm 
inhibits BCR destabilization……………………………………………………...70 
 
3.3. Mutation of the transmembrane tyrosine of μm  
blocked dissociation of μm from Ig-α/Ig-β………………………………………72 
3.4. A20Y/F cells induce BCR-mediated signal transduction ………………………..77 
 
3.5. The association of antigen-bound μm with CCV  
requires the transmembrane tyrosine of μm ……………………………………..79 
 
3.6. The transmembrane tyrosine of μm is required  
for antigen processing…………………………………………………………….84 
 
3.7. The transmembrane tyrosine of μm is required  
for antigen presentation ………………………………………………………….85 
 
 3.8. Surface MHC class II expression is comparable 
   between A20WT and A20Y/F cells………………………………………………86 
 
 3.9. Exposure of the transmembrane region of μm alone  
is insufficient to induce the association of receptors with CCVs………………...89 
 
 3.10. Phosphorylation of clathrin heavy chain is undetectable in A20 cells………….91 
 x
LIST OF ABBREVIATIONS  
 
Abbreviations 
BCR = B cell antigen receptor 
BLNK = B cell linker protein 
CART = conserved antigen receptor transmembrane  
CCVs = clathrin-coated vesicles 
CTB = cholera toxin B subunit  
ER = endoplasmic reticulum  
ERK = extracellular-signal-regulated kinase  
ITAM = immunoreceptor tyrosine-based activation motif  
LAB = linker for activation of B cells 
LAMP-1+ = lysosome-associated membrane protein-1 positive 
MHC = major histocompatibility complex  
MIIC = MHC class II peptide-loading compartments 
NP = nitrophenyl 
PAGE = poly acrylamide gel electrophoresis 
PC = phosphorylcholine 
TEM=transmission electron microscopy. 
WT = wild type 
 xi
Y/F = Y587F 
YXXØ motifs =X: any amino acid, Ø: bulky hydrophobic residue 






Chapter I. Introduction and background 
1. 1. Role of the B cell antigen receptor (BCR) during development and humoral 
immune response  
The BCR is a multi-chain immune recognition receptor that serves multiple functions 
throughout B cell development (1). At early stages of development, the pre-BCR complex 
triggers proliferative expansion, allelic exclusion and developmental progression to the 
immature stage (2-4). The first tolerance checkpoint occurs when immature B cells express a 
functional BCR. Cells expressing self-reactive BCR are negatively selected upon excessive 
BCR crosslinking to induce cell death via apoptosis or receptor editing as a means to 
eliminate autoreactivity (3). Negative selection eliminates more than 90% of total B cells 
generated in the bone marrow and allows approximately 10% of B cells to exit to the 
periphery, where naïve, transitional B cells continue to mature (5). At the mature stage of B 
cell development, the BCR serves as a specific receptor that binds foreign antigens. Upon 
ligation, the BCR initiates the humoral immune response by relaying intracellular signals and 
by focusing antigens to the endosomal system (6). This results in processing and presentation 
of antigenic peptides in the context of major histocompatibility complex (MHC) class II 
molecules to cognate helper CD4+T cells. The ultimate outcome of B cell activation is a 
generation of plasma cells that produce antigen-specific antibodies. To accomplish this 
variety of functions, B cells control the quality of surface BCR expression and the functions 
of BCR by utilizing a complex, yet organized network of receptor-mediated signal 
transduction.  
 
1. 2. Structure and surface expression of the BCR complex 
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The BCR complex is composed of the antigen binding subunit, membrane immunoglobulin 
(mIg) and the signaling subunit, disulfide-linked Ig-α/Ig-β (7). The association of μm and Ig-
α/Ig-β is non-covalent (8). The antigen binding subunit consists of two immunoglobulin 
heavy chains (IgH) and two light chains (IgL). Assembly of the BCR complex and surface 
expression is regulated by chaperon molecules that regulates transport of properly assembled 
receptors from the endoplasmic reticulum (ER) to the cell surface (9, 10). Germ line-
transcribed, newly synthesized μ-heavy chains (μm) and light chains are assembled into mIg 
and retained by calnexin in the ER (11). Calnexin-mediated ER retention is a checkpoint for 
quality control, thereby preventing misfolded or aberrantly glycosylated proteins from 
reaching the cell surface (12). For the assembly of multi-chain receptor complexes such as 
MHC class I and class II molecules, T cell receptor (TCR)-CD3 complexes, and the BCR 
complexes, a single chain of the receptor complex is held by calnexin until the other subunits 
associate (13-15). Specifically, calnexin binds the transmembrane region of μm of the BCR 
complex until Ig-α/Ig-β assembles onto μm (16). In the absence of Ig-α/Ig-β, mIg remains 
calnexin bound in the ER. Thus, Ig-α/Ig-β releases μm from the calnexin-binding site and 
allows subsequent processing of μm. Upon release of calnexin, the fully assembled BCR 
complex travels quickly to the cell surface via the Golgi apparatus.  
 
The association of the BCR complex is mediated by protein-protein interactions between 
transmembrane regions of μm and Ig-α/Ig-β (17). The transmembrane region of μm exhibits 
a conserved antigen receptor transmembrane (CART) motif that shares sequence 
conservation with other membrane immunoglobulins including mIgD, mIgG, mIgE, mIgA 
and TCR complex (18). This sequence conservation suggests a potential role of the CART 
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motif in associating with other integral transmembrane proteins in the hydrophobic 
environment of the lipid bilayer. The CART motif of μm is characterized by polar patches 
containing polar amino acids (tyrosine, serine, threonine) and aromatic, hydrophobic amino 
acids (phenylalanine, valine, leucine) near the carboxy- terminal end of the transmembrane 
domain. Modeling of μm using the α-helical wheel predicts that the conserved CART 
residues align on one side of the helix (18). This orientation likely provides a protein-protein 
interacting face for Ig-α/Ig-β (19). Mutagenesis studies reveal a functional role for the CART 
motif in BCR assembly and function (10, 19-25). Although some studies disagree, the 
general consensus is that surface expression of mIg and its function in signal transduction 
and antigen presentation depends on the association of Ig-α/Ig-β through the carboxy-
terminal polar patches of the CART motif.  
 
Mutagenesis studies of μm provide evidence that μm associates with Ig-α/Ig-β through the 
transmembrane regions. Most studies focus on the conserved polar residues near the putative 
carboxy-terminus of the transmembrane region and the three amino acid residues of the 
cytoplasmic domain of μm. Shaw et al. uses a panel of B cell clones transfected with wild 
type and mutated forms of μm to define a complete correlation between intact signaling of 
the receptor and the ability of the μm to associate with Ig-α/Ig-β (22). The cytoplasmic 
domain of μm is composed of short, positively charged amino acids (Lys-Val-Lys; KVK) 
and has no intrinsic enzymatic activity. However, deletion of KVK completely abolishes the 
ability of B cells to induce signal transduction, evidenced by failure to mobilize intracellular 
Ca2+ upon stimulation with multi-valent antigen or anti-μm antibody (22, 25). In contrast, 
substitution of KVK to a similarly charged, but distinct Arg-Ile-Arg (RIR) sequence sustains 
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Ca2+ mobilization (22). This indicates that the presence of the cytoplasmic tail of μm is 
critical for proper signal transduction, although the exact sequence is dispensable. A non-
conservative mutation of polar residues, tyrosine (Y587) and serine (S588) within the 
carboxy-terminal region of μm to valines (YS to VV) results in a complete loss of the 
intracellular Ca2+ response (11, 22). This indicates that removal of hydroxyl groups from 
tyrosine and serine disrupts the signaling ability of receptors. Importantly, the inability of 
these mutants (deletion of KVK and substitution of YS to VV) to mobilize intracellular Ca2+ 
correlates with failure of μm to associate with Ig-α/Ig-β and to induce protein 
phosphorylation (23). Coincident with lack of Ca2+ flux, these mutants also fail to activate 
cognate T cells following incubation with antigen (22). These findings suggest that signal-
competence and the ability of B cells to present antigen to cognate T cells correlate with 
association with Ig-α/Ig-β.  
 
A more subtle change, tyrosine (Y587) to phenylalanine (Y to F) in the carboxy-terminal 
polar patch retains the ability to mobilize intracellular Ca2+ and induce protein 
phosphorylation (22, 26). Consistently, Y to F mutation of μm maintains the association with 
Ig-α/Ig-β, however, despite intact Ig-α/Ig-β, cells bearing these mutated receptors fail to 
present antigen to T cells (26). This indicates that the elimination of a single hydroxyl group 
at tyrosine 587 of μm maintains the association of μm with Ig-α/Ig-β and the ability to 
transduce BCR-signals. In contrast, this single point mutation eliminates antigen endocytosis, 
targeting of endocytosed antigen to intracellular compartments, and peptide loading onto 
MHC class II molecules (26). Thus Y587 separates the signal transduction and antigen 
presentation functions of the BCR.  
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 Surface expression of mIg requires association with Ig-α/Ig-β (27, 28). Introducing IgH and 
IgL into non-lymphoid cells fails to promote expression of surface mIg (29). However, 
surface mIgM expression occurs when Ig-α/Ig-β are provided. Interestingly, receptors 
harboring a deletion of the KVK or a substitution of YS to VV are expressed at high levels 
on the cell surface, despite the lack of Ig-α/Ig-β association (11, 22, 25). This suggests that 
these mutations cause intrinsic changes such as converting the BCR from an integral 
transmembrane protein to a GPI (glycosyl-phosphatidyl-linositol)-linked protein in the case 
of the KVK deletion (25). In the case of the YS to VV mutation, surface mIgM expression in 
the absence of Ig-α/Ig-β is presumed to be due to spontaneous release from calnexin (26). It 
is thought that conferring hydrophobicity at tyrosine and serine residues alters the 
glycosylation of μm, resulting in reduced avidity for calnexin. This relieves the restraint on 
μm required for ER-retention and leads to spontaneous surface expression.  
 
1. 3. BCR-mediated signal transduction 
One of the major functions of the BCR is to transduce intracellular signals upon receptor 
crosslinking (2-4, 30-32). Antigen ligation activates the src-family protein kinase, Lyn which 
rapidly phosphorylates the cytoplasmic tail of Ig-α/Ig-β at tyrosine residues within the 
immunoreceptor tyrosine-based activation motif (ITAM). Phosphorylated ITAMs create 
docking sites for tandem Src-homology (SH) 2 domains of the cytosolic protein tyrosine 
kinase, Syk. Recruitment of Syk to the ITAMs of Ig-α/Ig-β is a key event that amplifies 
multiple signaling cascades, including phosphatidylinositol-3-(PI3) kinase, Ras, Rho-family 
GTPase, and phospholipase C (PLC) γ activation. Syk, along with Bruton’s tyrosine kinase 
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(Btk), activates PLCγ, resulting in the cleavage of phosphatidylinositol-4,5-biphosphate 
(PIP2) to inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG). Parallel to PLCγ 
activation, PI3K is recruited to the plasma membrane. Both PLCγ and PI3K act on the same 
substrate, PIP2, however, in contrast to PLCγ, PI3K phosphorylates PIP2 to generate 
phosphatidylinositol-3,4,5-triphosphate (PIP3). Accumulation of PIP3 provides a membrane 
binding site for the pleckstrin homology (PH) domain of both PLCγ and Btk, creating a 
positive-reinforcement loop. Activation of these cascades elevates and prolongs the 
intracellular Ca2+ flux, promoting nuclear translocation of nuclear factor κB (NF-κB), 
nuclear factor of activated T cells (NFAT), activated c-Jun amino-terminal kinase (JNK), p38, 
and extracellular-signal-regulated kinase (ERK) (33). In addition, signal strength such as 
affinity or avidity of antigen is reflected at the level of intracellular Ca2+ elevation by 
oscillating spikes of varying duration, interval and amplitude (34). Ultimately, this influences 
gene transcription that regulates many B cell responses, including proliferation, plasma cell 
differentiation, antibody secretion and the induction of tolerance.  
 
The membrane location of BCR-mediated signal transduction is controversial, however, 
considerable evidence suggests that lipid rafts exist in the plasma membrane of living cells 
and play an important role in receptor-mediated signal transduction (7, 35). Lipid rafts are 
enriched in cholesterol and glycosphingolipids that contain saturated fatty acid side-chains 
(e.g. GM1 gangliosides), thus they appear as relatively ordered membrane patches (36). This 
structural feature allows lipid rafts to be resistant to solubilization by non-ionic detergent and 
to run at low density on sucrose gradients. Detergent-resistant, low density microdomains of 
the plasma membrane can be detected by western blotting with cholera toxin B subunit 
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(CTB) which binds to GM1 (35). An important biological feature of lipid rafts is selective 
partitioning of signaling molecules. Positive signaling proteins such as Lyn, G proteins, Ras 
GTPase, and adaptor protein linker for activation of B cells (LAB) constitutively partition 
into lipid rafts through the modification of saturated fatty acids (37, 38). In contrast, certain 
phosphatases such as CD45, CD22, and SH2 domain-containing protein tyrosine 
phosphatase-1 (SHP-1) are excluded from lipid rafts in resting cells (37, 39).  Due to a rigid, 
ordered structure, lipid rafts have been thought to function as scaffolds for membrane 
trafficking and signal transduction.  
 
In mature, resting B cells, most BCR complexes are detected outside of lipid rafts. However, 
crosslinking of the BCR induces translocation into lipid rafts (37, 40). Although the regulator 
of lipid raft entry remains unknown, receptors within lipid rafts are readily phosphorylated by 
lipid raft-associated Lyn at the ITAMs of Ig-α/Ig-β (37, 39). This amplifies the signaling 
cascade by recruiting other proteins including PI3K and PLCγ to the lipid rafts, where PIP2 is 
enriched (41). It has been proposed that initial recruitment of signaling proteins to lipid rafts 
triggers formation of multiple signaling molecule complex (Btk, Vav, Rac, and F-actin) 
termed ‘signalosome’ that stabilizes and prolongs receptor-mediated signals (4). Although it 
is accepted that lipid rafts regulate the duration of BCR-mediated signals, it remains unclear 
if lipid rafts are the only sites that facilitate BCR-signal transduction (42, 43). Disruption of 
lipid rafts with pharmacological reagent does not affect BCR-mediated intracellular Ca2+ 
influx (44). In addition, blocking of lipid rafts has no effect on ERK activation in human B 
cells (43). These findings indicate that some BCR-signal transduction occurs independently 
of lipid rafts. 
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 1. 4. BCR-mediated antigen processing and presentation 
In addition to signal transduction, the BCR captures soluble, multivalent antigen and 
internalizes for transport to the endocytic pathway (45). B cells are good antigen-presenting 
cells because the BCR focuses 1000-fold less antigen than fluid phase-mediated uptake (46). 
In addition, the BCR processes antigen and expresses peptide-MHC class II complexes 
within 1 hr of antigen exposure (26). This efficient antigen binding to the BCR ensures rapid 
and targeted responses to antigens (47). Endocytosis of antigen-bound BCR complexes 
occurs mainly through clathrin-coated vesicles (CCVs) (48). Clathrin is a intracellular protein 
that forms a lattice around protein cargo localized on the plasma membrane (49, 50). Three 
sets of clathrin heavy and light chains trimerize into a clathrin triskelion that serves as a 
building block for CCVs (51). Endocytosed BCR-antigen complexes transit to the early 
endosome, where some of the unoccupied receptors recycle back to the surface (52). After 
transit to the early endosome, internalized antigen-BCR complexes are delivered to late 
endosomes where the complexes persist for prolonged periods of times (53). Antigen 
internalized via fluid phase endocytosis is rapidly delivered to lysosomes and degraded by 
lysosomal proteases (53). Antigen delivered to late endosomes by the BCR is processed into 
peptides by capthepsin (54). Newly synthesized MHC class II molecules are retained in the 
ER by association with chaperone invariant chain (Ii) and directly delivered to the endocytic 
pathway, where the antigen-BCR complex is localized (55, 56). As the MHC class II-Ii 
complex progresses through the endocytic pathway, proteases degrade Ii, leaving the CLIP 
(class II-associated invariant chain peptide) fragment of Ii in the peptide-binding cleft of the 
MHC class II molecule (57). Accessory molecules, H-2/HLA-DM dislodge CLIP from MHC 
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class II and load processed antigenic peptides (58, 59) . The Bulk of peptide loading occurs 
in the late endocytic vesicles, termed MHC class II-peptide loading compartment (MIIC) 
and/or other subcompartments such as the early endocytic class II-containing vesicles 
(CIIVs) (60). Peptide-MHC class II (pMHC II) complexes then move to the cell surface to 
present the peptide to cognate CD4+ helper T cells (53). The majority of unbound peptides 
move to the lysosome and are degraded by lysosome-associated proteases (47, 53). The 
persistence of antigen-BCR complexes in the late endocytic vesicles correlates with 
prolonged surface expression of pMHC II (53). The nature of antigen or strength of BCR-
signal does not change the itinerary of endocytosed antigen through the endocytic pathway, 
but receptor crosslinking accelerates the internalization and targeting of antigen (61).   
 
Antigen presentation by the BCR is critical for B cells to act as immune effectors. 
Specifically, the immune response to most protein antigens requires the recognition of 
peptide-MHC class II complexes on B cells by CD4+ T cells (6). This T-dependent antigen 
response is initiated in spatially organized lymphoid tissues, such as lymph node and spleen. 
The initial antigen recognition tethers T cell onto the cellular contact site with the B cell, and 
this focal point develops into elaborate cellular synapse by which intracellular information is 
exchanged (35). Antigen-stimulated T cells produce cytokines and upregulate co-stimulatory 
molecules such as B7.1 and CD40 ligand (CD40L). The local cytokine milieu and co-
stimulatory molecules then activate B cells and trigger proliferative clonal expansion and 
differentiation into antibody-secreting plasma cells. In lymphoid tissue, this interaction is 
responsible for short-lived plasma cell differentiation and the development of the germinal 
center (GC), where the affinity of the BCR is fine-tuned to produce high-affinity long-lived 
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plasma cells and memory cells (6). Thus, BCR-mediated targeting of antigens to the 
endosomal system is essential for initiating humoral immune responses.  
 
1. 5. Endocytic motif 
Clathrin-mediated endocytosis is an integrated series of molecular events that include 
clathrin-coat formation, vesicle invagination, vesicle fission, and uncoating in the cytoplasm 
(51). Studies have discovered that multiple accessory and adaptor proteins are implicated in 
protein–protein and protein-lipid interactions between the endocytic apparatus and the 
cytoskeletal elements (62-64). Analysis of clathrin formation in living cells provides a 
unifying model that the clathrin adaptor complex, AP-2, plays a central role in sorting protein 
cargo and forming a stable platform on the plasma membrane to initiate clathrin cage 
assembly (65). From these platforms, clathrin triskelion and cargo proteins are transferred 
into forming vesicles that rapidly move laterally and then move towards the cytoplasm 
through actin polymerization (49). Progressively, vesicles invaginate and are released into 
the cytoplasm as free clathrin-coated cages. The invagination and fission of vesicles appear 
to require the GTPase-activity of dynamin, an accessory molecule that regulate actin 
polymerization (66). Following endocytosis, uncoating of clathrin occurs rapidly through the 
catalytic activity of Hsc70 and ATPase-harboring protein, auxilin (49). While clathrin coat 
components are released into the cytoplasm for recycling, protein cargo is transported into 
the endocytic pathway.  
 
The AP-2 complex is composed of 4 subunits and serves as a bridge between the 
transmembrane receptor and the forming clathrin cage. AP-2 binds receptors via the μ2 
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subunit and the clathrin/accessory molecules via α and β subunits (51). Studies suggest that 
phosphorylation of the μ2 subunit is necessary to induce conformational changes in the AP-2 
complex, allowing the binding of protein cargo (67). Upon phosphorylation, the AP-2 
complex recognizes protein cargo at short linear amino acid sequences, called endocytic 
sorting motifs or trafficking motifs.  Well-characterized canonical sorting motifs are 
tyrosine-based YXXØ motifs (X: any amino acid, Ø: bulky hydrophobic residue) and di-
leucine (LL) motifs that bind the μ2 and/or the β subunits of AP-2 complex (50, 68). Other 
non-canonical endocytic motifs such as ubiquitin have also been suggested (69). Ubiquitin is 
a 76-amino acid polypeptide and can be conjugated to lysine side chain of target proteins. 
Poly-ubiquitination regulates turnover of intracellular proteins by tagging a signal for 
degradation via the 26S proteasome. In contrast, single or oligo-ubiquitination acts as an 
endocytic sorting signal for protein that guides proteins to the endosomal system (69-74).  
 
For the BCR, the ITAMs (YXXL) of Ig-α/Ig-β have been thought to be the endocytic sorting 
motif due to their structural resemblance with a canonical tyrosine-based motif (75-78). 
While no direct evidence is available to show the interaction of ITAM and AP-2 complex, 
this idea is challenged by the studies showing that the phosphorylated form of the tyrosine-
based sorting motif (PO4-YXXØ) has a significantly reduced affinity to the μ2 subunit of the 
AP-2 complex (79). Given that BCR crosslinking induces phosphorylation at the tyrosine 
residues of the ITAMs, it is likely that activated BCR complexes are inhibited from binding 
the AP-2 complex. In addition, evidence for a role of the ITAM in receptor internalization 
and subsequent antigen processing/presentation has been contradictory. Some reports suggest 
that although the Ig-β cytoplasmic tail is required for antigen presentation, mutation of 
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tyrosine of the ITAM has no effect on receptor internalization (76, 77). Others report that 
cells harboring mutations within the BCR at sites other than the ITAM fail to present 
peptides to T cells despite intact ITAM motifs (26). These data argue against the idea that the 
ITAM motifs of Ig-α/Ig-β are the endocytic sorting motif for antigen entry into the endocytic 
pathway. This raises the possibility that a novel endocytic motif regulates BCR entry into the 
endocytic pathway.  
 
1. 6. BCR-mediated signals regulate trafficking of receptor-antigen complexes through 
the endocytic pathway 
The two functions of the BCR are signal transduction by Ig-α/Ig-β and endocytosis of 
antigen by μm. Although seemingly independent, these functions are interrelated such that 
BCR-induced signals accelerate endocytosis of antigen and guide the trafficking of antigen 
through the endosomal system (77, 80, 81). BCR crosslinking recruits cytoplasmic Syk to the 
plasma membrane, where Syk promotes and stabilizes the formation of tightly aggregated 
BCR-antigen complexes (82). Lyn activation is required for the internalization of aggregated 
BCR-antigen complexes and for phosphorylation of clathrin heavy chain during endocytosis  
(82, 83). The valency of antigen influences the rate of internalization, as crosslinking with 
polyvalent antigen prolongs the BCR aggregates on the plasma membrane (84). This 
concomitantly increases the duration of protein tyrosine kinase activation, slows down 
receptor internalization, and reduces movement of antigen to the late endosomes. BCR-
mediated signals also increase cellular F-actin and change the organization of actin filaments 
to promote receptor internalization and trafficking (85). Perturbing actin filaments does not 
affect BCR signal transduction, but dramatically reduces the movement of the BCR from the 
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early endosome to the late endosomes/lysosomes (85). This suggests that BCR signals target 
actin filaments to regulate and guide the trafficking of antigen-receptor complexes through 
the endosomal system. Collectively, these findings show how signaling molecules intersect 
the process of internalization and movement of BCR-antigen complexes to the endocytic 
pathway. 
 
Following endocytosis, phosphorylation of Ig-α/Ig-β ITAM tyrosines is required for the 
access of antigen to MHC class II peptide-loading compartments (MIIC), as chimeric 
receptors expressing either subunit alone fail to reach MIIC, yet internalize normally (76, 78). 
Specifically, proper sorting of antigen to the MIIC requires the recruitment of Syk, B cell 
linker protein (BLNK), Vav, and Grb2 to phosphorylated ITAM of Ig-α (86). In addition, 
BCR-mediated signals reorganize, fuse, and acidify the transient MIIC-like compartments 
into invariant chain (Ii)- and MHC class II-rich large vesicles (81). These vesicles become 
the primary site for processing of endocytosed antigen and loading of peptides. These studies 
demonstrate an important role for BCR-mediated signal transduction in the targeting and 
processing of antigen within the endocytic pathway. 
 
1. 7. Early events in BCR-mediated antigen endocytosis 
Although BCR-mediated signals regulate antigen processing, the initial events that guide the 
entry of antigen-bound receptors to the endocytic pathway remain poorly understood. Early 
studies suggested that endocytosis occurred via CCVs (48). Subsequently, lipid-mediated 
receptor internalization is proposed when it is found that the BCR translocates into lipid rafts 
following antigen stimulation and raft-associated receptors and GM1 are targeted to the MHC 
 14
class II peptide-loading compartments (MIIC) (37, 40). This study suggests that upon 
receptor translocation, lipid rafts act as platforms for the entry of the BCR into the endocytic 
pathway. However, from this study, it is not shown if the BCR directly internalizes from lipid 
rafts or if the raft-associated BCR moves laterally in the membrane and internalizes by a raft-
independent mechanism. A unifying model that links lipid raft- and clathrin-mediated 
receptor endocytosis comes from a study showing that BCR-signals in lipid rafts modify 
clathrin through Lyn-dependent phosphorylation (83). Inducible phosphorylation of clathrin 
correlates with BCR uptake. This suggests that BCR-mediated antigen endocytosis occurs 
through a subset of clathrin that is constitutively associated with lipid rafts. These 
conclusions are questioned, however, by a study showing that the extent of BCR endocytosis 
is not affected by the disruption of lipid rafts (44). This study demonstrates that the bulk of 
antigen-bound receptors are internalized through a pathway independent of lipid rafts. 
Furthermore, this study suggests that raft-associated receptors have a different intracellular 
itinerary than the majority of receptors internalized through CCVs (44). An independent 
study shows that although lipid rafts are uniformly distributed across the plasma membrane, 
few associates with CCVs, suggesting that CCVs and lipid rafts localize to separate sites on 
the plasma membrane (87). While the precise mechanism of BCR-mediated endocytosis 
remains to be elucidated, these studies show that BCR-mediated signal transduction and early 
endocytic events are interrelated.  
 
1. 8. BCR desensitization and destabilization 
Upon initial antigen encounter, naïve B cells transduce robust signals, but become less 
responsive to subsequent antigen engagement. This phenomenon is known as receptor 
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desensitization (88). Desensitization of B cells is characterized at the molecular level as an 
inability to modulate intracellular Ca2+ and to induce phosphorylation of receptor-proximal 
kinases and Ig-α/Ig-β. For many receptors, desensitization is either due to rapid 
internalization of receptors or recruitment of negative signaling regulators to the receptors 
(89, 90). This results in a reduced availability of receptors for extracellular ligands or muting 
of signaling cascades at the receptor level. However, BCR desensitization does not correlate 
with reduced surface receptor expression level, inability of μm to bind antigen, or qualitative 
changes in BCR-signaling cascades (91). At a desensitizing dose of antigen, approximately 
25% of the surface receptor pool is occupied by antigen but the remaining 75% of receptors 
bind antigen but fail to induce a phospho-tyrosine response (88). This indicates that for some 
self-antigens, surface receptor level is maintained during desensitization. In addition, despite 
diminished induction in tyrosine phosphorylation, Lyn remains competent to bind and be 
activated by exogenous phospho-ITAM-containing peptides, suggesting Lyn from 
desensitized cells is functional but not activated (88). These observations indicate that 
activation is disrupted downstream of antigen binding of μm, but upstream of activation of 
ITAM and receptor-proximal kinase. Thus, desensitized cells remain competent to bind 
antigen through μm, but fail to subsequently transmit signals to Ig-α/Ig-β, hence failing to 
activate downstream effectors. This suggests that the phenotype of unresponsiveness is at the 
level of the receptor complex.  
 
This hypothesis is tested in a study demonstrating that receptor desensitization also 
destabilizes the BCR complex (91). This is shown by a 2-fold decrease in the amount of Ig-
α/Ig-β following antigen stimulation. BCR destabilization requires receptor-mediated signal 
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transduction and the activation of Syk and Lyn (91). Importantly, destabilized Ig-α/Ig-β 
heterodimers remain responsive to anti-Ig-β stimulation, consistent with the observations that 
function of Ig-α/Ig-β ITAM and receptor-proximal kinases in desensitized cells remain intact 
(88). This suggests that antigen ligation with BCR induces the quantitative and/or qualitative 
changes in interaction between μm and Ig-α/Ig-β and BCR destabilization is a possible 
mechanism that induced the unresponsiveness of desensitized BCR. However, from this 
study, it is not known if the BCR complex becomes transiently destabilized by antigen 
stimulation, hence representing biochemical instability or if the receptor subunits (μm and Ig-
α/Ig-β) physically dissociated.  
 
1. 9. Role of BCR destabilization in maintaining tolerance 
The nature of antigen and the availability of T cell help determine the fate of B cells 
following antigen encounter. Under conditions where foreign antigens bind the BCR and 
cognate T cell help is available, B cells undergo activation, proliferation, and differentiation 
to antibody-secreting plasma cells. However, binding of the BCR with self-antigen induces 
receptor desensitization, and lack of cognate T cell help maintains the cellular 
unresponsiveness of B cells. This unresponsive state is termed anergy (92). While the role of 
BCR destabilization in antigen targeting, B cell activation and antibody secretion is currently 
not known, its role in anergy is suggested by several studies. In many immunoglobulin (Ig) 
transgenic mouse models of B cell tolerance, B cells exhibit reduced tyrosine kinase 
activation, increased basal Ca2+ level, and constitutively elevated Erk (93-97). In these 
models, surface mIg levels are maintained, facilitating chronic binding of self antigen to 
autoreactive B cells. This suggests that in these low-affinity Ig transgenic models of anergy, 
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desensitization contributes to the unresponsive state of autoreactive B cells. In the in vitro 
model of BCR desensitization, antigen binding to only 25% of the surface receptor pool 
desensitizes the remaining BCR pool (~75%) that presumably lacks antigen. This suggests 
that receptor desensitization functions “in-trans” such that unbound receptors become 
unresponsive when a small number of receptors are ligated. This idea is tested in a study by 
Vilen et al., where a panel of B cells expressing both signal-competent and signal-
incompetent receptors is used to mimic antigen-bound and unbound receptors during 
desensitization (98). The study shows that coaggregation of signal competent and signal 
incompetent receptors prevents ITAM phosphorylation, Syk activation, Ca2+flux, and the 
upregulation of the B cell activation marker, CD69. This study proposes that the inclusion of 
desensitized receptors within functional BCR aggregates disrupts the spatial organization of 
receptor-aggregate, thereby inhibiting the activation of key signaling molecules. Although it 
remains to be tested whether BCR signaling is trans-modulated by desensitized receptors in 
vivo, this study suggests that destabilization-mediated receptor desensitization plays a key 






Chapter II. Biophysical nature of BCR destabilization 
; Independent trafficking of Ig-α/Ig-β and μm is facilitated  
by the dissociation of the BCR complex. 
(adopted from the publication by Jin Hyang Kim, Lorraine Cramer, Heather Mueller, Bridget 
Wilson, and Barbara Vilen. Journal of Immunology 175:147-154, 2005)
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Introduction 
The humoral immune response is initiated upon antigen binding to the B cell antigen receptor 
(BCR).  The BCR, composed of membrane immunoglobulin noncovalently associated with 
the Ig-α/Ig-β heterodimer, functions to transduce intracellular signals and to accelerate 
antigen targeting to the endocytic pathway (47, 80, 99).  These functions are interrelated as 
BCR-induced signals promote efficient targeting of antigen into the late endosome through 
the activation of Syk and BLNK (77, 86).  In addition, BCR-mediated signals induce 
transient formation of antigen-processing compartments and promote acidification of the late 
endosome (81, 100).  These studies demonstrate an important role for BCR-mediated signal 
transduction in the targeting and processing of antigen in the endocytic pathway. 
 
The initial events that guide entry of antigen-bound receptors to the endocytic pathway 
remain poorly understood.  Early studies suggested that endocytosis occurred via CCVs, 
however subsequent studies showed that raft-associated BCR and the glycosphingolipid GM1 
were targeted to the class II peptide-loading compartments (37, 48).  This indicates that GM1-
rich lipid rafts may act as platforms for the entry of receptors into the endocytic pathway.  
Another study linked raft- and clathrin-mediated endocytosis, showing that Lyn 
phosphorylated clathrin heavy chain (83).  This proposes that the endocytosis of receptor 
occurs through a subset of clathrin that is constitutively associated with lipid rafts.  These 
conclusions were questioned however when it was shown that the extent of BCR endocytosis 
was not affected by the disruption of lipid rafts, demonstrating that the bulk of antigen-bound 
receptors are internalized through a pathway independent of lipid rafts (44).  Furthermore, 
this study suggested that raft-associated receptors had a different intracellular itinerary than 
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the majority of receptors internalized through CCVs.  An independent study showed that 
although lipid rafts were uniformly distributed across the plasma membrane, few associated 
with CCVs (87).  While the precise mechanism of BCR-mediated endocytosis remains to be 
clarified, these studies show that BCR-mediated signal transduction and early endocytic 
events are interrelated.  
 
We previously showed that BCR-mediated signal transduction destabilized Ig-α/Ig-β from μ-
heavy chain (μm), as evidenced by a reduced association of Ig-α/β with μm following BCR 
ligation (91).  However, it remained unclear if destabilization represented a physical 
dissociation of the receptor complex, how the destabilized BCR components partitioned on 
the plasma membrane, and what role BCR destabilization played in targeting antigens to the 
endocytic pathway.  Herein we demonstrate that the BCR complex physically dissociates 
upon antigen stimulation.  Analysis of destabilized receptors showed Ig-α/Ig-β in GM1-rich 
microdomains in the absence of μm.  In contrast, antigen-bound μm associated with CCVs 
in the absence of Ig-α/Ig-β.  Further, conditions that prevented BCR destabilization also 
inhibited the association of antigen-bound μm with CCVs.  These data show that physical 
dissociation of the receptor complex allows μm and Ig-α/β to traffic independently on the 
plasma membrane and promotes clathrin-mediated endocytosis.  
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Materials and Methods 
Cell Lines.  The K46μ and M12g3r cell lines express nitrophenyl (NP)- or 
phosphorylcholine (PC)-specific mouse IgM and were maintained as previously described 
(101).   
 
Antibodies and Reagents.  The monoclonal antibodies b-7-6 (anti-μ), HM79 (anti-Ig-β), 
anti-Ig-α, anti-Lyn and anti-Syk have been previously described (88, 91).  Primary 
antibodies include goat anti-mouse IgM (Jackson ImmunoResearch), mouse anti-clathrin 
heavy chain (Ab-1, Oncogene Research Products), mouse anti-phosphotyrosine (Ab-2, 
Oncogene Science), unconjugated or biotin-conjugated cholera toxin B (List Biological), and 
rabbit anti-cholera toxin (Sigma).  Gold (10 nm)-conjugated antigens (NP8BSA, PC10BSA) 
were prepared as previously described (102).  Herbimycin (Calbiochem) was used either at 5 
μM for 16 hrs or at 100 μM for 30 minutes.  At these concentrations of inhibitor, viability 
remained >95% , Lyn-phosphorylation was completely inhibited, and BCR destabilization 
was inhibited (91).  
 
Isolation of Detergent-Insoluble Microdomains.  K46μ cells (20-30x106) were stimulated 
with NP8BSA (1 μg/10x106cells/ml) for the indicated times, resuspended to a final 
concentration of 108 cells/ml in ice-cold MES buffer containing 0.1% Triton-X 100 and 
incubated 30 minutes on ice.  Cells were dounce homogenized and lysates were mixed with 
80% sucrose/MES to a final concentration of 40% sucrose.  Samples were overlaid with 
MES/30% sucrose, followed by MES/5% sucrose, and then spun for 20 hrs at 37,000 rpm.  
Fractions from the gradient were separated on 10% SDS-PAGE, then immunoblotted.   
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Immunofluorescence Staining.  M12g3r cells were stimulated with PC10BSA (1μg/ml) for 
5-10 minutes and then stained with goat anti-mouse IgM and Cy3-anti-goat IgG.  Cells were 
spun onto poly-D-lysine (Sigma)-coated coverslips, fixed with 3% paraformaldehyde and then 
stained with biotinylated anti-Ig-β  followed by streptavidin-Alexa 488 or streptavidin-Alexa 
647.  To assess the association of μm or Ig-β with lipid rafts, cells were further stained for 
GM1 with cholera toxin B, rabbit anti-cholera toxin B and anti-rabbit IgG-Alexa 647.  To 
assess the association of receptor component with clathrin, cells were permeabilized with 
100% ice-cold MeOH then stained with mouse anti-clathrin and anti-mouse IgG-Alexa 488.  
Samples were observed using the Zeiss Axioplan 2 fluorescence microscope and digitally 
deconvolved using SlideBook (Intelligent Imaging Innovation).  The percent colocalization 
between the μm, Ig-β and clathrin was determined by statistical analysis of a masked area of 
the image.  
 
Plasma Membrane Sheets and Transmission Electron Microscopy.  Cells grown on 
poly-D-lysine coated coverslips were stimulated with gold-conjugated antigens for the 
indicated times.  Plasma membrane sheets were prepared as described (102, 103).  
Unstimulated cells were fixed with paraformaldehyde prior to staining.  Samples were 
examined using the Zeiss EM 10C and images obtained at a magnification of 25,000.  The 
criteria used to assess the association of μm and Ig-α/Ig-β was established using membranes 
from the IgM/α chimeric cell line.  On these membranes, the average distance between 10 
nm (μm) and 5 nm (Ig-α) gold particles was found to be 11 ± 2 nm (SEM; standard error of 
mean).  To be conservative, 10 nm and 5 nm gold particles separated by greater than 30 nm 
were considered dissociated.  The criteria used to claim the dissociation of μm from Ig-α/Ig-
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β was established by measuring the actual distance from 10 nm gold particles (μm) to the 
nearest 5 nm gold particles (Ig-α) and displayed as mean ± SEM.  The association of 
receptor components with CCVs was defined by the presence of μm or Ig-α in vesicles that 
stained specifically for clathrin, and that exhibited a prototypic polyhedral structure.  
 
Analysis of BCR Endocytosis.  The kinetics of internalization of PC10BSA-HRP was 
determined using a colorimetric assay that quantitates HRP activity (104).  Briefly, M12g3r 
cells were either non-treated or herbimycin-treated (5 μΜ) for 16 hr at 37°C, then labeled 
with PC10BSA-HRP (1μM) for 30 minutes on ice.  After washing, cells were incubated in 
37°C to allow receptor internalization.  At each corresponding time-point, internalization 
was stopped with ice-cold buffer.  The HRP activity remaining on cell surface was measured 
by adding substrate o-phenyenediamine-2HCl (Sigma) and H2O2 and read at OD492.
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Results  
Antigen stimulation localizes Ig-α/Ig-β to lipid microdomains in the absence of μm.  
Antigen ligation of the BCR destabilizes Ig-α/Ig-β from μm as evidenced by the inability to 
coprecipitate stoichiometric amounts of Ig-α/Ig-β with μm (91). As shown in Figure 2.1 and 
previously described, immunoprecipitation of the BCR complex from antigen stimulated 
K46μ cells failed to coprecipitate stoichiometric amounts of Ig-α/β (lane 1 compared to lane 
2) despite precipitation of comparable amounts of μm.  Quantitation of the amount of Ig-α 
relative to the amount of μm revealed a 2-fold decrease in Ig-α/β. Given the dual role of the 
BCR in signal transduction and receptor-mediated endocytosis, we reasoned that receptor 
destabilization might provide a mechanism for antigen to rapidly enter the endocytic pathway 
while simultaneously allowing Ig-α/Ig-β to sustain signal transduction.  This predicts that 
BCR destabilization represents a physical separation of μm from Ig-α/Ig-β thereby allowing 
independent trafficking on the plasma membrane.   
 
Antigen ligation of the BCR was previously shown to induce translocation of the receptor 
complex to lipid rafts (37).  Although this study showed both Ig-α and μm in lipid rafts, it 
was unclear if the levels of μm relative to Ig-α were stoichiometric.  To determine if BCR 
destabilization was evident in lipid microdomains, we fractionated unstimulated and antigen 
stimulated cells on a sucrose gradient (Figure 2.2A).  Further, we simultaneously 
immunoprecipitated the BCR complex from unstimulated cells (Figure 2.2B; lane 7), to 
define the stoichiometry of sheathed receptors, thus providing a means to accurately 
determine immunoblot exposure times.  Antigen-stimulated K46μ cells showed induced 
protein tyrosine phosphorylation within detergent insoluble (fraction 5) and soluble fractions 
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(fractions 10 and 11) (Figure 2.2A).  Immunoblot analysis revealed that fraction 5 contained 
lipid microdomains as evidenced by the presence of GM1 and Lyn (Figure 2.2A; bottom panel 
and 2.2B middle panel).  In addition, fraction 5 showed the translocation of Ig-α, but not μm, 
within 1 minute of antigen stimulation (Figure 2.2B; top and bottom panels).  The amount of 
Ig-α recovered from fraction 5 was similar to the amount immunoprecipitated from 5x106 
unstimulated cells (Figure 2.2B; anti-Ig-α blot, lane 2 compared to lane 7).  However, the 
amount of μm in fraction 5 was undetectable compared to the amount expected from 5x106 
sheathed receptors (Figure 2.2B; anti-μ blot, lanes 2-6 compared to lane 7).  The data show 
Ig-α in lipid microdomains in the absence of μm, suggesting that BCR destabilization 




Figure 2.1. Antigen stimulation induces BCR destabilization in K46μ cells. Anti-μ and 
anti-Ig-α immunoblots of anti-μ immunoprecipitates. K46μ cells were either unstimulated 
(lane 1) or stimulated with NP8BSA (1μg/10x106 cells/ml) for 50 minutes (lane 2).  Cells 
were lysed and the BCR complex was immunoprecipitated with anti-μ.
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 Figure 2.2.  Destabilized Ig-α/Ig-β resides in lipid microdomains in the absence of μm.  
(A) Cell lyates from unstimulated and antigen (NP8BSA)-stimulated (7 minutes) K46μ cells 
were separated on sucrose gradients and immunoblotted for tyrosine-phosphorylated proteins 
(upper panel) and GM1 (lower panel).  (B) Anti-μ, anti-Lyn and anti-Ig-α immunoblots from 
GM1-containing lipid microdomains (fraction 5).  Lane 1: unstimulated-, lane 2-6: NP8BSA-
stimulated cells, lane 7; anti-μ immunoprecipitate from unstimulated, unfractionated K46μ 
cells.  The data presented are from a single experiment representative of five. 
 28
Ig-β fails to cocap with μm following antigen stimulation.   
To assess if physical dissociation was evident in live cells, we examined unstimulated and 
antigen-stimulated B cells for their membrane distribution of Ig-β and μm following anti-
μ−induced capping.  We reasoned that if antigen ligation induced a physical separation of 
the receptor complex, subsequent capping of μm would leave 50-75% of Ig-α/Ig-β outside 
the cap (91).  The analysis was performed on M12g3r cells since they fail to express surface 
Ig-α/Ig-β in the absence of transfected μm (Figure 2.3).  Within 30 minutes of antigen 
stimulation, M12g3r cells showed a loss of coprecipitated Ig-α/β, and treating cells with the 
src-kinase inhibitor, herbimycin, prevented this effect (Figure 2.4).  Under this condition of 
herbimycin treatment (100 μM for 30 minutes), Lyn-phosphorylation were completely 
inhibited and Syk-phosphorylation was partially inhibited (Figure 2.5). This suggests that 
BCR-mediated signals regulate receptor destabilization, consistent with previous studies (91).  
Immunofluorescence staining of unstimulated cells showed a 40% colocalization of μm and 
Ig-β (Figure 2.6; top panels).  In addition, lipid microdomains stained for GM1 were evenly 
distributed on membrane.  Following antigen stimulation the amount of Ig-β that colocalized 
with μm was reduced to only 14% (Figure 2.6; middle panels).  This observation was not 
due to an unexpected consequence of antibody-induced capping, Ig-α/Ig-β anti-μ maintained 
the colocalization of μm and Ig-β when cells were treated with herbimycin to inhibit 
destabilization (Figure 2.6; bottom panels).  In addition, inhibiting kinase activation induced 
μm and Ig-β to co-cap independent of GM1 aggregation.  This suggests that receptor 
destabilization occurs outside lipid microdomains.  Since the lipid microdomains did not 
visibly aggregate upon antigen stimulation, the capped μm/ Ig-α/Ig-β complexes (herbimycin 
treatment) colocalized with some of these regions (Figure 2.6; bottom panels).  Therefore, 
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we cannot exclude the possibility that association of the BCR with a small fraction of lipid 
microdomains is sufficient to induce the dissociation of 50-75% of Ig-α/Ig-β from μm during 
BCR destabilization.  Nonetheless, the 3-fold decrease in the colocalization of Ig-β and μm 
following antigen stimulation supports the notion that BCR destabilization represents a 
physical separation of μm from Ig-α/Ig-β.  
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Figure 2.3. M12g3r cells fail to express surface Ig-α/Ig-β in the absence of transfected 
μm. Expression of Ig-β on M12.4 (thin line) compared to M12g3r (thick line) cells.  M12.4 
cells stained with anti-μ are shown as the negative control (gray line).  A representative of 2 






    
Figure 2.4. Herbimycin inhibits BCR destabilization in M12g3r cells.  Anti-μ and anti-
Ig-α immunoblots of anti-μ immunoprecipitates from M12g3r cells.  Cells were either 
unstimulated (lane 1) or stimulated with PC10BSA (1μg/5x106 cells/ml) for 30 minutes (lane 
2) or treated with herbimycin at 100 μM for 30 minutes followed by antigen stimulation.  
Cells were lysed in 1% Chaps and the BCR complex was immunoprecipitated with anti-μ.  
The data are representative of 3 experiments.  
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 Figure 2.5. Herbimycin inhibits BCR-mediated signal transduction.  Anti-
phosphotyrosine immunoblots of anti-Lyn (upper, left panel) or anti-Syk (upper, right panel) 
immunoprecipitates.  M12g3r cells were either untreated (lanes 1 and 2 of each panel) or 
herbimycin-treated (lane 3 of each panel) and stimulated with PC10BSA (1μg/5x106 cells/ml) 
to assess BCR sensitivity.  Anti-Lyn (bottom, left panel) and anti-Syk (bottom, right panel) 
immunoblots were done sequentially.  The data are representative of 2 experiments and has 
previously been shown (91). 
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 Figure 2.6. Ig-β fails to cocap with μm following antigen stimulation.   
M12g3r cells were either fixed prior to staining (top panels) or stimulated with PC10BSA for 
10 minutes (middle panels) or pretreated with herbimycin as in Figure 4, followed by antigen 
stimulation (bottom panels).  Cells were stained for μm (Cy3), Ig-β (Alexa 488) and GM1 
(Alexa 647).  Approximately 50% of all cells showed good capping and comparable staining 
of three fluorochromes.  The percent colocalization of Ig-β and μm was quantitated from 19-
27 random cells obtained from 2-6 independent experiments. 
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Destabilization of the BCR complex represents a physical dissociation of Ig-α/Ig-β from 
μm.  The data strongly suggest that Ig-α/Ig-β dissociated from μm following antigen 
stimulation.  However, we could not formally exclude the possibility that Ig-α/Ig-β was re-
expressed outside the anti-μ-induced cap during stimulation and staining.  To address this, 
we assessed the location of Ig-α/Ig-β relative to μm immediately post-stimulation using 
native membrane sheets viewed by transmission electron microscopy (TEM).  This method 
afforded greater resolution than confocal microscopy, and unlike ultrathin sectioning, 
allowed the analysis of large pieces of native membrane (102, 103).  In addition, it allowed a 
more accurate assessment of the kinetics of destabilization. To induce receptor 
destabilization and simultaneously label antigen-bound μm, we prepared gold-conjugated 
PC10BSA and tested its ability to induce tyrosine phosphorylation following BCR 
crosslinking of M12g3r cells.  As shown in Figure 2.7, the level of tyrosine phosphorylation 
induced by gold-conjugated PC10BSA was comparable to that induced by unconjugated 
antigen. Native membranes prepared from M12g3r cells that were fixed prior to the addition 
of gold-conjugated antigen exhibited colocalization of 10 nm (gold-conjugated antigen) and 
5 nm (Ig-α) gold particles, confirming the association of μm and Ig-α in unstimulated cells 
(Figure 2.8A, Table 1).  The percent colocalization was determined by the frequency of 10 
nm particles that associated with 5 nm particles (see Materials and Methods for the criteria of 
assessment).  Of the 3830 PC10BSA-gold particles (10 nm) counted, 46% were associated 
with Ig-α-gold particles (5 nm), with an average distance of 18 ± 2 nm separating small and 
large gold particles.  In contrast, cells stimulated for 5 minutes showed 7% colocalization, 
with the average distance of 218 ± 5 nm separating the receptor components (Figure 2.8B, 
Table 1).  The 6-fold decrease in the association of μm with Ig-α, and the large increase in 
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the distance separating the receptor components, confirm a physical dissociation of the BCR 
complex within 5 minutes of receptor ligation.  
 
To establish if the low frequency of μm that associated with Ig-α in resting cells (46%) 
reflected the limitations of staining the BCR complex or constitutive dissociation of resting 
receptors, we determined the frequency of μm/Ig-α association in cells expressing a chimeric 
BCR.  The chimeric receptor contained a NP-specific extracellular domain fused to Ig-α 
cytoplasmic tail (IgM/α) and was predicted to show 100% colocalization of μm and Ig-
α (105).   However, only 47% of chimeric μm colocalized with Ig-α (Figure 2.8C, Table 1).  
Thus, the relatively low frequency of μm/Ig-α association in unstimulated cells reflected the 
inability to label the components of the BCR at saturating levels.  This finding is consistent 
with the confocal microscopy study where 40% of μm colocalized with Ig-β (Figure 2.6).  
Nonetheless, the 6-fold decrease in the colocalization of μm with Ig-α clearly indicates a 
dissociation of the receptor complex following ligation.  The Ig-α staining was specific in 
that an unrelated, isotype-matched antibody failed to stain membranes (Figure 2.8D). 
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 Figure 2.7. Gold-conjugated PC10BSA induces tyrosine phosphorylation. Anti-
phosphotyrosine immunoblot of M12g3r cells either unstimulated or stimulated for 1 minute 
with unconjugated or gold (10 nm)-conjugated PC10BSA (0.5 μg/5x106 cells/ml).  The data 
are representative of 3 experiments.
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 Figure 2.8. Antigen stimulation induces a physical dissociation of μm from Ig-α/Ig-β.  
(A) Unstimulated M12g3r cells were fixed prior to μm staining or, (B) stimulated with 
PC10BSA-gold (10 nm, large arrows) for 5 minutes prior to the preparation of native 
membranes then stained for Ig-α (5 nm, small arrows). (C) Cells expressing chimeric BCR 
were stimulated with NP8BSA-gold (10 nm, large arrows) for 5 minutes prior to the 
preparation of native membrane then stained for Ig-α (5 nm, small arrows). (D) Cells were 
stained with unrelated isotype matched antibody, Her2/Neu (5 nm), after preparing native 
membrane sheets. Circles depict clusters of colocalized μm (10 nm) and Ig-α (5 nm). Insets 
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display higher magnification of association/dissociation of μm and Ig-α. Arrowheads in (A) 
and (D) depict the membrane edge.  Bar = 100 nm.  
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Table 1.  Assessment of subcellular localization of μm and Ig-α on native membrane 











Total PC10BSA-gold particlesa 3830 3525 3249 
2543 
(NP8BSA-gold) 
PC10BSA-gold particles colocalized 
with Ig-α-gold particles 
46% 7% 7% 47% 
 
Cells were either fixed prior to μm staining (t = 0) or stimulated with PC10BSA-gold (10 nm) 
or NP8BSA-gold (10 nm).  Native membrane sheets were prepared and stained on the 
intracellular side for Ig-α (5 nm).  Membrane localization of gold particles was analyzed by 
TEM at 25,000x.  
aGold particles (10 nm) were counted from at least 55 different native membrane sheets 
obtained from 8-10 different experiments.   
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Antigen-bound μm associates with clathrin-coated vesicles following BCR ligation.  
Previous studies suggested that endocytosis of antigen-bound receptors occurred through 
CCVs (48).  To assess if receptor destabilization played a role in this process, we viewed 
intact cells using confocal microscopy for the distribution μm, Ig-β and clathrin following 
antigen stimulation.  We chose a timepoint of 5-10 minutes based on the EM study (Figure 
2.8 A-B).  Images of Z-axis planes from unstimulated cells revealed that μm and Ig-β were 
evenly distributed on the plasma membrane, while clathrin was distributed throughout the 
cytoplasm with a slightly higher concentration at the membrane (Figure 2.9; upper panels).  
In unstimulated cells, only 5% of μm and 3% of Ig-β colocalized with CCVs.  Following 
antigen stimulation, this pattern changed dramatically such that 68% of μm became clathrin-
associated in large foci at the membrane (Figure 2.9; lower panels).  However, the majority 
of Ig-β remained distributed over the plasma membrane with only 2% of Ig-β associating 
with CCVs, similar to the findings in Figure 2.6 middle panels.  These data indicate that 
antigen stimulation promotes the association of μm with CCVs, but not the association of Ig-
β.        
 
To further assess the distribution of μm, Ig-α/Ig-β and clathrin in native membranes, we 
analyzed native membrane sheets by TEM.  As shown in Figure 2.10A and Table 2, 14% of 
PC10BSA-gold (10 nm) resided within CCVs (5 nm) in native membranes from resting cells.  
Within five minutes of BCR ligation, the distribution of μm changed dramatically, revealing 
a 4-fold increase in the association of PC10BSA-gold (10 nm) with clathrin (5 nm) (Figure 
2.10B, Table 2).  The staining for clathrin heavy chain and antigen was specific since a gold-
labeled, isotype-matched polyclonal antibody and gold-conjugated BSA failed to stain the 
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membrane (Figure 2.10C, 5D).  These data show that antigen-bound μm associates with 






Figure 2.9. Antigen stimulation colocalizes μm with CCVs.  Cells were fixed prior to 
staining (upper panels) or stimulated with PC10BSA for 10 minutes (lower panels) then 
stained for μm (Cy3), Ig-β (Alexa 647) and clathrin (Alexa 488).  The percent colocalization 
of μm or Ig-β with CCVs was quantitated from 15 cells obtained from 3 independent 
experiments.  Approximately 50% of all cells showed good capping and comparable staining 
of all three fluorochromes.  Of these, 80% exhibited caps that contained μm and clathrin.  
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Figure 2.10. BCR ligation induces the association of antigen-μm, but not Ig-α, with 
clathrin-coated vesicles.  (A) Cells were fixed, then stained with PC10BSA-gold (10 nm, 
large arrows) and clathrin (5 nm, small arrows) or, (B) stimulated for 5 minutes prior to 
preparation and staining of native membranes.  Inset displays a higher magnification of μm 
association with CCVs.  The large and small arrows represent some of the large and small 
gold particles.  (C) Cells were prepared as in (A), and then stained with an isotype matched, 
polyclonal mouse IgG antibody (5 nm).  Arrows depict 10 nm gold particles.  (D) Cells 
were stimulated with BSA-gold (10 nm) for 5 minutes prior to the preparation of native 
membranes, and then stained for clathrin (5 nm).  Arrows depict 5 nm particles staining 
CCVs.  (E) Cells were fixed, and then stained for Ig-α (12 nm, large arrows), and clathrin (5 
nm, small arrows) or, (F) stimulated with PC10BSA for 5 minutes prior to the preparation and 
staining of native membranes. (G) Cells were fixed, and then stained for Ig-α (5 nm, small 
arrows) and clathrin (10 nm, arrow heads), or (F) stimulated with PC10BSA for 5 minutes 
prior to the preparation and staining of native membranes. The data are representative of 5-10 
experiments. Bar = 100 nm. 
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Table 2.  Assessment of subcellular localization of μm, Ig-α and CCVs on native 
membrane sheets in M12g3r cells. 
Time (minutes) 0 2 5 10 20 
Total PC10BSA-gold particlesa 1750 1833 3212 1995 2064 
PC10BSA-gold particles  
Colocalized with CCVs 
14% 55% 47% 45% 54% 
Total Ig-α gold particlesb 987 7556 2812 1283 2147 
Ig-α-gold particles  
Colocalized with CCVs 
20% 16% 23% 13% 11% 
 
Cells were either fixed prior to μm staining (t = 0) or stimulated with PC10BSA-gold (10 nm) 
or unconjugated antigen.  Native membrane sheets were prepared and stained on the 
intracellular side for clathrin (5 nm) and/or Ig-α (12 nm).  Membrane localization of gold 
particles was analyzed by TEM at 25,000x.  
aGold particles (10 nm) were counted from 14-39 different native membrane sheets obtained 
from 2-7 different experiments.  
bGold particles (12 nm) were counted from 18-76 different native membrane sheets obtained 






Ig-α fails to translocate into clathrin-coated vesicles following BCR ligation.  
Collectively, the data demonstrate a physical separation of Ig-α/Ig-β from μm following 
antigen ligation of the BCR.  The findings that antigen-bound μm associates with CCVs 
while Ig-α resides in lipid microdomains suggest that μm associates with clathrin in the 
absence of Ig-α/Ig-β. To determine if antigen stimulation induced comparable recruitment of 
Ig-α into CCVs, we  stained native membranes for clathrin (5 nm) and Ig-α (12 nm).  In 
resting cells, 20% of Ig-α associated with CCVs (Figure 2.10E, Table 2).  However, there 
was no increased association of Ig-α with CCVs following antigen stimulation (Figure 2.10F, 
Table 2).  These findings were not due to the inability of the anti-Ig-α antibody to recognize 
phosphorylated protein since this antibody immunoprecipitated phosphorylated Ig-α (88).  In 
addition, the density of Ig-α staining in membranes from unstimulated cells compared to 
antigen-stimulated cells did not change.  The failure to colocalize was not due to the 
inability of 12 nm gold particles (Ig-α) to enter the clathrin lattice, since reversing the gold 
particle size did not change the results (Figure 2.10G-H).  This suggests that although some 
Ig-α constitutively colocalizes with clathrin, antigen-ligation of the BCR does not induce 
further association.  
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Unsheathed μm preferentially associates with clathrin-coated vesicles.   
The selective association of μm, but not Ig-α, with CCVs suggests that destabilization may 
play a role in entry of μm into CCVs.  However, the low basal association of Ig-α with 
CCVs, regardless of antigen stimulation, raised the possibility that a small pool of BCR 
entered CCVs as an intact complex.  To resolve this, we assessed the frequency at which 
μm and Ig-α colocalized within the same CCVs.  CCVs containing PC10BSA-gold (10 nm) 
particles were identified by their prototypic polyhedral structure.  In resting cells, 10% of the 
PC10BSA-gold (10 nm) particles found within CCVs were associated with Ig-α (5 nm) 
(Figure 2.11A).  Following antigen stimulation, there was a 4-fold increase in the 
association of μm with CCVs (Table 2) however; only 3-4% of the μm were associated with 
Ig-α (Figure 2.11A).  This indicates that unsheathed μm preferentially enters CCVs.   
 
Destabilization of Ig-α/Ig-β is required for μm association with clathrin-coated vesicles.   
To further assess the role of BCR destabilization in antigen entry to CCVs, we treated cells 
with a kinase inhibitor to prevent BCR destabilization (Figure 2.4)(91).  We reasoned that if 
BCR destabilization was required for clathrin-mediated endocytosis, inhibiting 
destabilization would diminish the translocation of μm to CCVs.  As shown in Figure 2.11B, 
μm failed to associate with CCVs in herbimycin-treated cells, suggesting that BCR 
destabilization facilitates the movement of antigen-bound μm to CCVs.  It remained possible 
that lack of μm association with CCVs was simply due to failure of receptor internalization.  
To directly assess if B cell receptors clear the membrane in the absence of kinase activation, 
we monitored the clearance of HRP-tagged antigen in untreated and herbimycin-treated 
M12g3r cells.  As shown in Figure 2.11C, receptor internalization in untreated or 
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herbimycin-treated cells occurred with comparable kinetics and magnitude.  Further, 
herbimycin treatment did not affect receptor clearance as detected by flow cytometry (Figure 
2.11D).  Collectively, conditions that prevented BCR destabilization also inhibited the 
association of μm with CCVs, suggesting that receptor destabilization is required for the 
entry of antigen to the endocytic pathway.  
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Figure 2.11. BCR destabilization facilitates the translocation of antigen-bound μm to 
CCVs.  (A) Native membranes from M12g3r cells were fixed prior to μm staining (time = 0) 
or stimulated with PC10BSA-gold (10 nm) for 2 and 5 minutes, then stained for Ig-α (5 nm).  
The number of PC10BSA-gold particles enumerated within CCVs was 419 (time = 0), 946 
(time = 2) and 1039 (time = 5), obtained from 55-83 membrane sheets.  (B) M12g3r cells 
were either untreated (open circle) or pretreated with herbimycin (closed circle) prior to 
stimulation with PC10BSA-gold.  The data are depicted as individual experiments with the 
average percent association of μm with CCVs represented by the line.  The number of 
PC10BSA-gold particles counted from herbimycin-treated cells was 1750 (time = 0), 1163 
(time = 2) and 2470 (time = 5) from 20-39 membrane sheets.  (C) Receptor internalization 
of PC10BSA-HRP was compared between untreated M12g3r cells (open circle) or cells 
pretreated with herbimycin (closed circle) at 5 μM for 16 hr.  (D). Receptor internalization 
of PC10BSA-biotin was compared between untreated M12g3r cells (open circle) or cells 
pretreated with herbimycin (closed circle) as in (C). Receptors that remained on the cell 
surface were stained with FITC-conjugated streptavidin. The data are from 4 experiments. 
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Discussion  
Our results show that receptor crosslinking induces a physical separation of Ig-α/Ig-β from 
antigen-bound μm.  Destabilized μm associates with CCVs while Ig-α resides in lipid 
microdomains.  These findings do not simply reflect movement of different pools of 
sheathed BCR to two locations, but rather independent trafficking; since Ig-α is rarely found 
in CCVs (Figure 2.10 E-F and Table 2) and insignificant amounts of μm are found in lipid 
microdomains (Figure 2.2B).  Collectively, the data support a model wherein equilibrium 
exists between Ig-α/Ig-β−sheathed receptors and unsheathed receptors.  In the absence of 
antigen, sheathed receptors predominate although some unsheathed receptors constitutively 
recycle through CCVs (Table 2; t= 0 min).  Upon antigen ligation, BCR-mediated signal 
transduction triggers receptor dissociation, shifting the equilibrium towards a predominance 
of unsheathed receptors and the association of antigen-bound μm with CCV. Another 
possible interpretation is that BCR ligation stabilizes dissociated receptors.  In confocal 
microscopy and TEM, the frequency of μm that colocalizes with Ig-α/Ig-β in resting cells 
was low (40% and 46% respectively).  However, staining of chimeric receptors revealed a 
similar colocalization frequency (47%).  This indicated an inability to label the components 
of the BCR at saturating levels rather than a large pool of dissociated receptors.  Consistent 
with this interpretation, the frequency of μm associated with CCV in resting cells was only 
14% (Figure 2.10, Table 2).  Thus, we interpret the data to show that BCR ligation induces 
receptor dissociation rather than stabilizing dissociated receptors.  
 
The location of BCR destabilization remains unclear (Figure 2.12). One possibility is that the 
sheathed BCR initiate signal transduction and receptor destabilization within lipid 
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microdomains (scenario A).  The dissociated μm leaves such that insignificant amounts of 
μm are detected (Figure 2.2B).  This could occur via microdomain-associated clathrin as 
suggested by Stoddart et al (83).  Nonetheless, some Ig-α/Ig-β remains in lipid 
microdomains to sustain signal transduction. We attempted to identify lipid microdomain-
associated clathrin on native membrane by staining Lyn and clathrin (Figure 2.13). The 
majority of Lyn stain was localized independent of clathrin (Figure 2.13A). In addition, 
antigen stimulation did not increase the association of Lyn with clathrin (Figure 2.13B), and 
reversing the size of gold to stain Lyn and clathrin did not change the results (Figure 2.13C-
D). This suggests that lipid microdomains stained with Lyn does not colocalize with clathrin. 
This is consistent with an independent study, showing that although lipid rafts are uniformly 
distributed across the plasma membrane, few associate with CCVs (106). Alternatively, the 
BCR dissociates on the plasma membrane prior to μm and Ig-α/Ig-β moving to CCVs or lipid 
microdomains (scenario B). Receptor destabilization promotes the association of μm with 
membrane-resident clathrin or a clathrin adaptor molecule.  This allows delivery of μm to 
the endocytic pathway while dissociated Ig-α/Ig-β translocates to lipid microdomains. The 
finding that sheathed receptors (herbimycin treated) mainly co-capped outside of GM1-rich 
lipid microdomains (Figure 2.6; bottom panels) suggests that BCR destabilization occurs 
prior to the movement of receptors to lipid microdomains.  However, further analysis is 
needed to confirm the location of destabilization.  Nonetheless, the data indicate that 
receptor dissociation precedes the targeting of μm to CCVs, hence only unsheathed μm is 
competent to enter CCVs.  A direct role for BCR destabilization in targeting of μm to CCVs 
is suggested by two findings.  First, inhibition of BCR destabilization prevents the 
association of μm with CCVs (Figure 2.11B).  Second, in the absence of receptor ligation, 
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the basal association of μm with clathrin occurs in the absence of Ig-α  (Figure 2.11A).  Thus 
BCR destabilization may provide an early regulatory step in the targeting of antigen to the 
endocytic pathway.  
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 Figure 2.12. Two scenarios for antigen-induced movement of the BCR to the endocytic 
pathway.  In scenario A, sheathed BCR moves to lipid microdomains and initiates signal 
transduction, resulting in receptor destabilization.  The dissociated μm rapidly leaves the 
lipid microdomains possibly by interacting with clathrin or chaperone molecules. Ig-α/Ig-β 
remains in lipid microdomains.  In scenario B, BCR destabilization occurs outside lipid 
microdomains, resulting in exposure of a site within μm that promotes association with 
clathrin or a clathrin adaptor molecule.  Dissociated Ig-α/Ig-β translocates to lipid 
microdomains in the absence of μm. 
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 Figure 2.13. Lipid rafts do not colocalize with CCVs. Cells were either fixed (A), (C) or 
stimulated with PC10BSA for 5 minutes (B), (D) prior to preparation and staining of native 
membranes. (A)-(B). Native membranes were stained with Lyn (12 nm, arrow heads) and 
clathrin (5 nm, small arrows). (C)-(D). Native membranes were stained with Lyn (5 nm, 
small arrows) and clathrin (12 nm, arrow heads).   
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A physical dissociation of the BCR complex was first suggested by the presence of Ig-α in 
lipid microdomains in the absence of μm (Figure 2.2B).  These findings contrast with a 
previous report claiming translocation of intact BCR complexes into lipid rafts (37).  We 
immunoprecipitated sheathed BCR from unstimulated cells as a means to quantitate the 
amounts of μm relative to Ig-α in lipid microdomains.  Establishing this stoichiometry was 
not shown in the earlier study, thus a small amount of μm in lipid rafts may have been 
amplified by a long immunoblot exposure time.  Consistent with this idea, we found that 
long exposures revealed a small amount of μm in lipid microdomains (Kim and Vilen, 
unpublished observations).  We attempted to confirm the association of Ig-α/Ig-β with lipid 
microdomains by staining rafts-associated molecules on native membranes. Studies have 
suggested that antigen stimulation induces the aggregation of lipid rafts, forming bigger 
patches of lipid microdomains within the plasma membrane (35). To define lipid raft 
aggregates on native membranes, we stained for Linker for B cell activation (LAB), Lyn or 
GM1 (Figure 2.14) (38).  However, we were unable to identify aggregates of these molecules 
following antigen stimulation.  This is similar to another study showing that the location of 
aggregated FcεR1 in native membranes does not correlate with the distribution of previously 
described “raft-associated” molecules (107). This suggests that the topographical relationship 
between membrane proteins and lipids is complex and dynamic, possibly due to the varying 




Figure 2.14. Antigen stimulation fails to induce the aggregation of lipid rafts-associated 
molecules. (A)-(B) Cells were fixed prior to staining (A), or stimulated with PC10BSA for 5 
minutes prior to native membrane preparation (B), and then stained for GM1 with cholera 
toxin (10 nm, arrow heads). (C)-(D) Cells were fixed prior to staining (C), or stimulated with 
PC10BSA for 5 minutes prior to native membrane preparation (D), and then stained for Lyn 
(5 nm, small arrows). (E)-(F) Cells were fixed prior to staining (E), or stimulated with 
PC10BSA for 5 minutes prior to native membrane preparation (F), and then stained for Linker 
for B cell activation (LAB; 5 nm, small arrows). 
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Clathrin-mediated endocytosis is facilitated by the interaction of clathrin-adaptor molecules 
with a receptor encoded ‘endocytic motif’ (65).  The structural resemblance of the Ig-α/Ig-β 
ITAMs to a canonical tyrosine-based YXXØ motifs (X: any amino acid, Ø: bulky 
hydrophobic residue) suggested their role as endocytic motifs (51, 75, 76, 78).  Our data 
show that μm preferentially enters CCVs in the absence of Ig-α/Ig-β (Figure 2.11A, Table 2), 
suggesting that an alternative mechanism is responsible.  This is consistent with studies 
showing that μm attaches to the cytoskeleton in the absence of Ig-α/Ig-β, and that signaling 
competent BCR mutants fail to process and present antigen despite the presence of intact Ig-
α/Ig-β (26, 110).  Other possible mechanisms to promote the entry of μm into CCVs may 
include ubiquitination or phosphorylation of μm (69, 70).  These modifications may induce 
receptor destabilization and simultaneously facilitate the association of antigen-bound μm 
with CCVs.  Alternatively, dissociation of Ig-α/Ig-β from μm may expose a non-canonical 
endocytosis motif that associates with an adapter molecule. 
 
Our data indicate that inhibiting the activation of src-family kinases prevents the association 
of μm with CCVs coincident with inhibiting BCR destabilization (Figure 2.11B, Figure 2.4).  
Others have shown that the src-kinase, Lyn, is responsible for the phosphorylation of clathrin 
heavy chain and the endocytosis of BCR through raft-associated clathrin (83).  Collectively, 
the data suggest a model wherein BCR-mediated signal transduction functions to dissociate 
μm from Ig-α/Ig-β, thus promoting association of μm with CCV; and to phosphorylate 
clathrin heavy chain, possibly preparing CCVs to receive BCR-bound antigen.  Currently, 
we cannot distinguish if receptor destabilization or clathrin phosphorylation initiates the 
association of antigen-μm with CCVs, if the events occur simultaneously, or if clathrin 
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phosphorylation is affected at our concentration of herbimycin.  However, despite the lack 
of kinase activation, receptor internalization occurred normally (Figure 2.11C-D).  This 
indicates that in the absence of clathrin association, the sheathed receptor complexes are 
internalized through routes other than CCVs. Consistent with this idea, lipid rafts and actin 
cytoskeleton have been implicated in receptor clearance (37, 44, 48, 78, 83).  In addition, 
previous studies have shown that clathrin-mediated internalization is not solely responsible 
for the clearance of receptors from the cell surface (71, 111-113).  However, this does not 
refute the importance of clathrin-mediated endocytosis, since productive processing of 
antigen internalized in the absence of kinase activation is unlikely.  Others have shown that 
kinase activation is required for clathrin heavy chain phosphorylation and BCR endocytosis 
through lipid rafts (83).  In addition, kinase activation is required for late endosome 
acidification and for the destabilization of the BCR (81, 91).  Thus, the fate of receptors 
internalized in the absence of kinase activation may be degradation (114).  It is important to 
note that previous studies showed that Lyn-deficiency impeded BCR internalization; whereas 
our data show normal receptor clearance in the presence of src-kinase inhibitors (82, 83).  
This discrepancy may reflect the different ligands used to crosslink the BCR.  Our study 
used bona fide antigen whereas the previous study used polyvalent crosslinkers, such as 
F(ab’)2 of anti-μ that have been reported to slow the rate of BCR endocytosis (84).  
Importantly, our data are consistent with studies showing that BCR mutants lacking the 
ability to transduce signals remain competent to internalize receptors (22, 25, 26).   
 
The immune response requires efficient antigen processing and presentation such that 
pathogen-derived peptides can be efficiently presented to T cells.  Our data extend previous 
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findings to address the biophysical nature of antigen-induced receptor destabilization and to 
show that receptor destabilization promotes entry of antigen-μm complexes into CCVs, while 
maintaining a pool of Ig-α/Ig-β within the GM1-containing lipid microdomains.  The rapid 
association of antigen-bound μm with CCV allows antigen to rapidly enter the endocytic 
pathway, while the association of unsheathed Ig-α/Ig-β with lipid microdomains allows 
sustained signal transduction and/or provides a pool of Ig-α/Ig-β to prime the recycling pool 







Chapter III.  The role of BCR destabilization in antigen processing 
; The transmembrane tyrosine of μ-heavy chain is required for BCR 
destabilization and entry of antigen into clathrin-coated vesicles. 
(Submitted to Journal of Immunology cutting edge by Jin Hyang Kim and Barbara 
Vilen, March, 2006) 
Introduction 
The BCR binds antigen and transduces signals that regulate many cellular functions, 
including the delivery of antigen for processing and presentation (80). Previous studies show 
that BCR-derived signals regulate antigen processing by guiding antigen-bound receptors to 
the MHC class II compartment and by promoting acidification of the late endosomes (77, 81). 
BCR-mediated signal transduction also destabilizes the receptor complex, reducing the 
amount of coprecipitable Ig-α/Ig-β that associates with μm (91). Recently, we showed that 
BCR destabilization represented a physical separation of Ig-α/Ig-β from μm (116). 
Following receptor crosslinking, μm separated from Ig-α/Ig-β by distances approximating 
180 nm. We showed that Ig-α/Ig-β was found in lipid rafts in the absence of μm, and that 
antigen-bound μm associated with CCVs in the absence of Ig-α. This indicates that 
endocytosis of antigen through CCVs is mediated by unsheathed μm, and that BCR 
destabilization occurs prior to the association of antigen-bound receptors with CCV. These 
findings suggest that BCR destabilization might be required for antigen presentation, and 
raised questions regarding the molecular mechanisms underlying dissociation of the receptor 
complex. 
 
The BCR complex is maintained by protein-protein interactions within the transmembrane 
regions of μm and Ig-α/Ig-β (7). The tyrosine-587 and serine-588 resides within the 
transmembrane region of human μm are critical for the assembly of the receptor complex. 
Loss of polarity on these residues leads to the expression of unsheathed μm on the cell 
surface (23). Elimination of a single hydroxyl group on the tyrosine residue preserves the 
intact BCR complex, but severely impairs BCR-mediated antigen presentation to T cells (26). 
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This indicates that despite an intact BCR complex, one or more molecular events are blocked 
prior to antigen presentation, and that the tyrosine residue within the μm transmembrane 
region is required for these events. In this study, we show that the transmembrane tyrosine 
regulates antigen-mediated BCR destabilization, and that this residue is required for the 
association of antigen-bound receptors with CCVs and antigen processing. Using 
immunoprecipitation and transmission electron microscopy (TEM), we found that mutation 
of the transmembrane tyrosine-587 to phenylalanine (Y587F;Y/F) failed to dissociate μm 
from Ig-α/Ig-β. In addition, this mutation abolished the association of antigen-bound μm 
with CCVs. In the absence of BCR destabilization, antigen entry in late endosomes and 
presentation of peptide antigen to T cells were severely impaired. However, at the time of 
BCR destabilization, phosphorylation of receptor-proximal and distal kinases was 
comparable to that induced by wild type (WT) receptors, indicating that attenuated BCR-
mediated signal transduction cannot account for the defects. Thus, the tyrosine residue within 
the μm transmembrane region is a site that regulates the dissociation of Ig-α/Ig-β from μm, 
and the association of antigen-bound μm with CCVs. The inability of Y/F receptors to enter 
CCVs resulted in a marked reduction in antigen presentation, indicating that entry of antigen 
to the endocytic pathway proceeds through CCVs. 
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Materials and Methods 
Cells: A20 murine lymphoma cells (IgG2a+, H-2d) transfected with phosphorylcholine (PC)-
specific human wild type (WT) or Y587F mutant (Y/F) IgM receptors were maintained as 
described (22). The A20Y587F receptors levels were expressed at approximately 75% of 
wild type levels (Figure 3.1A).  To directly compare these two lines we regularly sorted the 
BCR levels of A20Y587F line to match the wild type cells (Figure 3.1B). The T cell 
hybridoma, DO11.10, is specific for OVA323-339 bound to I-Ad.   
 
Antibodies and reagents: Gold-labeled antigens and antibodies for immunoblotting, 
immunofluorescence, and immunogold labeling were previously described (116). Rat anti-
LAMP-1was kindly provided by Dr. Marcus Clark (University of Chicago, IL). Rabbit anti-
Syk was kindly provided Dr. John Cambier (University of Colorado Health Science Center, 
CO). Goat anti-human IgM was purchased from Jackson ImmunoResearch Laboratories 
(West Grove, PA), FITC-conjugated anti-human IgM from Amersham Bioscience 
(Piscataway, NJ) and anti-Erk1/2 from Cell Signaling (Danvers, MA). Rat anti-mouse MHC 
class II (M5/114) was used to measure the level of IAd.  
 
Immunoprecipitation and surface biotinylation. Cells were immunoprecipitated with 
CNBr-activated Sepharose 4B-conjugated antibodies as described (116). Cells were surface 
biotinylated as described (91). Briefly, cells were washed three times with PBS and then 
resuspended at 10 × 106/ml in PBS containing 80-100 μg/ml EZ-LinkTMSulfo-NHS-LC-
Biotin (Pierce, Rockford, IL). After incubation for 10 minutes at room temperature, the cells  
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 Figure 3.1. Surface expression level of human IgM in A20 cells. A20WT (thick line) and 
A20Y/F (thin line) cells were stained with FITC-conjugated anti-human IgM. Cells stained 
with isotype control antibody are shown as a dotted line. (A) The A20Y/F receptor levels 
were expressed at approximately 75% of wild type levels before sorting. (B) BCR levels of 
A20Y/F cells were matched to the wild type cells after sorting. 
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were washed twice with cold PBS containing 15 mM glycine, resuspended at 5 × 106/ml in 
IMDM containing 2% FCS, and then stimulated with antigen. 
Preparation of plasma membrane sheets and immunogold labeling for TEM. 
Preparation of plasma membrane sheets has been described (116). The criteria used to assess 
the association of μm and Ig-α/Ig-β was previously established in the IgM/α chimeric cell  
line wherein the average distance was found to be 11 nm (116). To be conservative, 10 nm 
and 5 nm gold particles separated by greater than 30 nm were considered dissociated. The 
association of μm with CCVs was defined by the presence of 10 nm gold particles (μm) in 
vesicles that stained specifically for clathrin (5 nm), and that exhibited a prototypic 
polyhedral structure. 
 
Immunofluorescence staining: Cells were stained for μm and Ig-β as described (116). 
Briefly, cells were fixed prior to labeling or labeled with Alexa 647-conjugated PC5BSA or 
biotin-conjugated anti-Ig-β (HM79) on ice for 30 minutes. BCR-labeled cells were incubated 
at 37°C for 30 minutes and fixed with 3% paraformaldehyde. LAMP-1 staining was done 
following permeabilization with 0.05% saponin for 1 hr, followed by Alexa 488-conjugated 
anti-rat IgG antibody.  
   
Antigen presentation assay: A20 transfectants were pulsed with PC3OVA (30μg/ml) or 
OVA antigen (300~1000μg/ml) for 24 hr, fixed with 1% paraformaldehyde and incubated 
with DO11.10 cells (30,000) for 24 hr as described (22). IL-2 secreted from T cells was 
measured by ELISA. 
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Results 
Mutation of the transmembrane tyrosine of μm inhibits BCR destabilization. 
Destabilization of the BCR complex leads to the dissociation of antigen-bound μm from the 
Ig-α/Ig-β signal transducing complex. The separation of Ig-α/Ig-β from μm requires kinase 
activation, and is followed by the entry of antigen-bound μm into CCVs (91, 116). This 
suggests that unsheathing of μm may be involved in the entry of antigen into the endocytic 
pathway. To elucidate the molecular events that regulate the dissociation of the receptor 
complex, we examined mutants of the μm transmembrane region. We reasoned that since Ig-
α/Ig-β non-covalently associated with μm through the transmembrane YS sequence (23), 
receptor destabilization might also involve these residues. Others had previously reported 
that receptors harboring mutations of both Y587 and S588 (YS/VV) failed to associate with 
Ig-α/Ig-β (22, 23). In contrast, μm harboring a point mutation at Y587 associated with Ig-
α/Ig-β (22). We obtained the A20 cells expressing wild type human μm (A20WT), or μm 
containing a point mutation at the transmembrane tyrosine (A20Y/F), and assessed if BCR 
destabilization was evident following antigen stimulation. To track the pool of surface 
receptors, we surface biotinylated prior to immunoprecipitation. As shown in Figure 3.2, 
A20WT cells stimulated with PC-BSA showed approximately 2-fold decrease in the amount 
of coprecipitated Ig-α, consistent with previous studies of the K46μ and M12g3r cell lines 
and splenocytes from 3-83 μδ immunoglobulin transgenic mice (91, 116). In contrast, 
stimulation of A20Y/F cells failed to decrease the amount of surface Ig-α associated with μm. 
This suggests that despite an intact BCR, mutation of the μm transmembrane tyrosine 







Figure 3.2. Mutation of the transmembrane tyrosine of μm inhibits BCR destabilization. 
Surface biotinylated cells (10x106 cells/ml) were either unstimulated, or antigen-stimulated 
for 30 minutes. The BCR complex was immunoprecipitated, proteins resolved by SDS-
PAGE, and immunoblotted with SA-HRP, followed by anti-Ig-α. The data are a 
representative of at least 5 experiments. 
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Mutation of the transmembrane tyrosine of μm blocked dissociation of μm from Ig-α. 
To assess if failure to destabilize Ig-α/Ig-β from μm was evident on the membrane, we 
viewed native membrane sheets stained for Ig-α and μm by TEM. We have previously used 
TEM to assess BCR destabilization, and others have used it to identify receptor domains on 
mast cell membranes (103, 116). Resting A20WT and A20Y/F cells stained with gold-
labeled PC10BSA (10 nm) and Ig-α (5 nm) showed 51% and 52% colocalization of μm and 
Ig-α (Figure 3.3 A and C, Table 3). This level of colocalization was consistent with our 
previous study where immunogold staining of μm and Ig-α on a chimeric receptor (μm/Ig-α) 
approximated 50% colocalization, likely due to the inability to label the BCR at saturating 
levels (116). Stimulation of A20WT cells with gold-PC10BSA reduced the colocalization of 
μm with Ig-α to 29% by 10 minutes (Figure 3.3 B, Table 3). Similarly, a 2-fold reduction 
was evident 5 minutes after antigen stimulation, consistent with previous observations (data 
not shown)(116). However, the μm and Ig-α expressed on the A20Y/F cells remained 
colocalized (54%) following 5 and 10 minutes of antigen stimulation (Figure 3.3D, Table 3). 
The staining was specific in that gold-BSA (Figure 3.3E), isotype matched, unrelated 
antibodies and secondary antibodies (Figure 3.3F) failed to stain the membranes. This 
indicates that the transmembrane tyrosine of μm is required for the dissociation of μm from 




Figure 3.3. Mutation of the transmembrane tyrosine of μm blocked dissociation of μm 
from Ig-α/Ig-β. Cells were either fixed prior to staining for μm (A), (C) or stimulated with 
PC10BSA-gold (10 nm) for 10 minutes (B)-(D). Native plasma membranes were prepared and 
stained for Ig-α (5 nm). (E) Cells were stained with BSA10gold (10 nm) and anti-clathrin (5 
nm) or (F) an isotype-matched, unrelated primary (anti-Neu) and secondary antibody (12 
nm) after preparing native membrane sheets. TEM images were taken at a magnification of 
25,000x. The numbers of 10 nm gold particles are tabulated in Table 3 and represent data 
from at least 12 different native membrane sheets representing 3 experiments. Arrow heads 
and small arrows indicate antigen (10 nm) and Ig-α (5 nm) or clathrin (5 nm) staining 
respectively; * indicates the membrane edge. Bar =100 nm.  
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Table 3. Assessment of subcellular localization of μm and Ig-α on native membrane 
sheets in A20WT and A20Y/F cells. 
 
 A20WT A20Y/F 
Time (minutes) 0 10 0 10 
Total PC10BSA-gold (10 nm)a 2722 2577 1928 3189 
Colocalization with Ig-α-gold (5 nm) 51% 29% 52% 54% 
 
Cells were either fixed prior to μm staining (t = 0) or stimulated with PC10BSA-gold (10 nm). 
Native membrane sheets were prepared and stained on the intracellular side for Ig-α (5 nm) 
or clathrin (5 nm). Membrane localization of gold particles was analyzed by TEM at 25,000x.  
aGold particles (10 nm) were counted from 12-14 different native membrane sheets obtained 
from 3 different experiments.   
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Mutation of transmembrane tyrosine of μm does not attenuate the BCR-mediated signal 
transduction. 
Previous studies showed that destabilization of the BCR complex required kinase activation, 
although the identity of the kinase(s) remains unknown (91, 116). We reasoned that despite 
the association of Ig-α/Ig-β with μm in the A20Y/F cell line, failure to induce optimal signal 
transduction might prevent receptor destabilization. To assess if the mutated receptor 
complex expressed by A20Y/F induced comparable BCR-mediated signal transduction, we 
measured the tyrosine phosphorylation of receptor proximal (Ig-β, Lyn, Syk) and distal 
effectors (Erk). We monitored their activation up to 30 minutes following antigen stimulation 
to analyze if BCR dissociation affects the signaling at time points when up to 50% of the 
surface receptors are known to internalize. As shown in Figure 3.4, at the time of BCR 
destabilization (1 and 5 minutes), antigen-induced tyrosine phosphorylation of all effectors 
were comparable between A20WT and A20Y/F cells, consistent with a previous study 
showing that both A20WT and A20Y/F cells induced comparable antigen-mediated Ca2+ 
mobilization (22). These data indicate that at the time of BCR destabilization (within 5 
minutes of receptor ligation), receptor-mediated signals are comparable between A20WT and 
A20Y/F cells. However, Ig-α/Ig-β fails to dissociate from μm in A20Y/F cells (Figure 3.3), 
indicating that BCR-mediated signal transduction defects do not explain the failure to 
destabilize the receptor complex. The activation of Ig-β and Syk appeared to diminish 
quickly in A20Y/F cells compared to A20WT cells in later time points (Figure 3.4; 15 and 30 
minutes); whereas Lyn and Erk remained to be comparable in two cell lines. The mechanism 
of this differential activation profile is not clear. However, it is possible that due to failure to 
dissociate BCR, the μm/Ig-α/Ig-β complex of A20Y/F cells internalize following antigen 
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ligation, leaving little Ig-α/Ig-β on the surface to sustain receptor-mediated intracellular 
signals. The activation of Syk may be more sensitive to the persistence of surface Ig-α/Ig-
β than that of Lyn and Erk, since Syk is a key molecule in forming the signalosome on the 
cell surface (30). This idea is supported by the immunofluorescence staining of μm and Ig-β 
in Figure 3.6 showing that Ig-β staining of A20Y/F cells was intracellular at 30 minutes of 




Figure 3.4. A20Y/F cells induce BCR-mediated signal transduction. A20WT and A20Y/F 
cells (10x106/IP, 5x106/WCL) were either unstimulated, or antigen-stimulated for the 
indicated times. Whole cell lysates were blotted for Erk; Ig-β,Lyn, and Syk were 
immunoprecipitated from the cell lysate and blotted for phospho-tyrosine and protein levels. 
The data are a representative of 3 experiments.  
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The association of antigen-bound μm with CCV requires the transmembrane tyrosine of 
μm. 
Our previous data showed that 91% of receptors within CCVs were unsheathed, suggesting 
that BCR dissociation occurred prior to entry of receptors into CCVs (116). To test whether 
receptors that remained competent to transduce signals, yet failed to dissociate μm from Ig-
α/Ig-β, were capable of entering CCVs, we quantitated the number of receptors associated 
with CCVs in the presence or absence of antigen stimulation. In unstimulated A20WT and 
A20Y/F cells, 7% or 8% of μm (10 nm) was associated with clathrin (5 nm) (Figure 3.5A 
and C, Table 4). Stimulation of A20WT cells induced a 3-fold increase in the association of 
μm with CCVs by 10 minutes (Figure 3.5B, Table 4). In contrast, stimulation of A20Y/F 
cells failed to induce the association of μm with CCVs (Figure 3.5D, Table 4). This suggests 
that although the Y/F mutation does not disrupt BCR-mediated signals (Figure 3.4), it fails to 
dissociate Ig-α/Ig-β from μm (Figure 3.3), and fails to promote association of antigen-bound 
μm with CCVs (Figure 3.5). This indicates that BCR-derived signals target the 
transmembrane tyrosine of μm to destabilize the receptor complex, and to facilitate the entry 
of antigen-bound μm into CCVs.  
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Figure 3.5. The association of antigen-bound μm with CCV requires the 
transmembrane tyrosine of μm. (A)-(D) Cells were either fixed prior to staining for μm, 
or stimulated with PC10BSA-gold (10 nm) for 10 minutes. Native plasma membranes were 
prepared and stained for clathrin (5 nm). TEM images were taken at a magnification of 
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25,000X. The numbers of 10 nm gold particles are tabulated in Table 4 and represent data 
from at least 11 different native membrane sheets representing 3 experiments. Arrowheads 
and small arrows indicate antigen (10 nm) and clathrin (5 nm) staining, respectively. Bar 
=100 nm. 
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Table 4. Assessment of subcellular localization of μm and CCVs on native membrane 
sheets in A20WT and A20Y/F cells. 
 
 A20WT A20Y/F 
Time (minutes) 0 10 0 10 
Total PC10BSA-gold (10 nm)a 1494 2861 1365 2847 
Colocalization with clathrin (5 nm) 7% 24% 8% 11% 
 
Cells were either fixed prior to μm staining (t = 0) or stimulated with PC10BSA-gold (10 nm). 
Native membrane sheets were prepared and stained on the intracellular side for clathrin (5 
nm). Membrane localization of gold particles was analyzed by TEM at 25,000x.  
aGold particles (10 nm) were counted from 11-21 different native membrane sheets obtained 
from 3 different experiments. 
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The transmembrane tyrosine of μm is required for antigen processing and presentation. 
Endocytosis of antigen-bound receptors leads to antigen processing, degradation, or receptor 
recycling. Although controversial, receptor internalization through lipid rafts has been shown 
to mediate antigen processing (37). Our data indicate that although the A20Y/F cell line 
transduces BCR-mediated signals, it fails to associate with CCVs (Figure 3.5), however, the 
A20Y/F receptor associates with lipid rafts (40). This raised the possibility that in the 
absence of clathrin-mediated endocytosis, lipid raft-mediated endocytosis could facilitate 
antigen presentation. To assess if blocking clathrin-mediated endocytosis affected antigen 
processing, we monitored the accumulation of fluorochrome-tagged antigen in the LAMP-1+ 
late endosomes following antigen stimulation (Figure 3.6). In unstimulated A20WT and 
A20Y/F cells, the majority of LAMP-1 staining was intracellular and the BCR staining was 
localized on the cell surface. Following stimulation of A20WT cells, antigens colocalized 
with the intracellular LAMP-1+ compartments and Ig-β remained on the cell surface (Figure 
3.6), consistent with the idea that dissociated μm targets antigen to the endocytic pathway. In 
contrast, stimulation of A20Y/F cells failed to promote antigen localization into the LAMP-
1+ compartments (Figure 3.6). Consistent to the finding that A20Y/F BCR fails to dissociate, 
the majority of Ig-β staining of A20Y/F cells was also intracellular, however, failed to 
colocalize with LAMP-1.  This suggests that in the absence of BCR destabilization, antigen 
processing is impaired.  Together, our findings show that lipid raft-mediated endocytosis 
cannot restore antigen processing in the absence of μm association with CCV.  
 
To confirm that antigen in the LAMP-1+ compartments reflected cell surface presentation of 
antigen, we quantitated the amount of IL-2 secreted by T cells upon recognition of processed 
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peptides presented by MHC class II molecules. A20WT cells pulsed with PC3OVA induced 
secretion of IL-2 by OVA323-339-specific DO11.10 T cells (Figure 3.7). In contrast, A20Y/F 
cells pulsed with PC3OVA failed to induce IL-2 secretion. This did not reflect changes in  
surface MHC class II expression (Figure 3.8) or overall defects in antigen processing because 
presentation of pinocytosed OVA was comparable between A20WT and A20Y/F cells (data 
not shown). The data indicate that in the absence of BCR destabilization and association of 
antigen-bound μm with CCVs, antigen processing and presentation are attenuated. This is 
consistent with the work of others (22), and consistent with the failure of antigen to reach the 
LAMP-1+ compartments (Figure 3.6). Thus, the transmembrane tyrosine of μm mediates 
BCR destabilization, and the association of antigen-bound μm with CCVs; requisite events in 
antigen processing and presentation.  
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 Figure 3.6. The transmembrane tyrosine of μm is required for antigen processing. Cells 
were either fixed prior to staining, or labeled and stimulated with Alexa 647-conjugated PC-
BSA or Ig-β (Alexa 546). After 30 minutes, cells were fixed, permeabilized, and stained for 
LAMP-1. Red arrows indicate the colocalization of antigen and LAMP-1. The data were 
quantitated from 21-30 cells from 3 independent experiments.
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Figure 3.7. The transmembrane tyrosine of μm is required for antigen presentation. 
A20WT (WT) and A20Y/F (Y/F) were pulsed with antigen (PC3OVA; 30μg/ml) for 18 hours, 
fixed and cultured with DO11.10 T cells for 24 hours. The amount of IL-2 secreted by the 
OVA-specific T cells was measured by ELISA. The data are from 4 experiments.
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Figure 3.8. Surface MHC class II expression is comparable between A20WT and 
A20Y/F cells. A20WT (open thick line) and A20Y/F (fill gray line) cells were stained with 
M5/114 (rat anti-mouse IA). Cells (open gray line) stained with secondary antibody 
(fluorochrome-conjugated anti-rat IgG) alone are shown as control.
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Discussion 
Antigen binding to the BCR induces destabilization of the BCR complex, an event that 
dissociates Ig-α/Ig-β from μm (91). Recently, we showed that BCR destabilization 
represented a physical dissociation of μm from Ig-α/Ig-β (116). TEM analysis of native 
membrane sheets showed that antigen-bound μm separated from Ig-α/Ig-β by distances 
greater than 180 nm. In addition, we found that antigen-bound μm associated with CCVs in 
the absence of Ig-α/Ig-β, while Ig-α/Ig-β resided in the lipid microdomains in the absence of 
μm (116). In this study, we demonstrated that BCR destabilization required the 
transmembrane tyrosine within μm. Mutation of Y587 created a BCR that associated with Ig-
α/Ig-β, transduced antigen–mediated signals (22)(Figure 3.4), yet failed to dissociate μm 
from Ig-α/Ig-β (Figure 3.3). Receptors that failed to undergo BCR destabilization failed to 
associate with CCVs (Figure 3.5) and to present antigen (22)(Figure 3.7). Collectively, these 
studies identify the transmembrane tyrosine of μm as playing a key role in receptor 
destabilization and the association of antigen-bound receptors with CCVs. In addition, the 
data show that clathrin-mediated endocytosis is the primary mode of antigen entry that 
promotes antigen processing/presentation.  
 
The exact role of BCR destabilization in the association of antigen-bound receptors with 
CCVs remains unclear. Our previous data indicated that greater than 90% of receptors within 
CCVs were unsheathed (116). Since Ig-α/Ig-β no longer associated with antigen-bound μm, 
the data indicates that association of antigen-bound μm with CCVs occurs by a mechanism 
other than the classical YXXΦ sorting motif. One possibility is that BCR destabilization 
reveals a novel endocytosis motif that is masked when Ig-α/Ig-β is associated with μm. To 
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assess if unsheathing of μm was sufficient to promote the association of antigen-bound 
receptors with CCVs, we determined the membrane localization of receptors that were 
expressed on the cell surface in the absence of Ig-α/Ig-β. Others have shown that mutation of 
Y587 and S588 prevented the association of Ig-α/Ig-β with μm, yet allowed unsheathed 
receptors to be expressed on the cell surface (22). Analysis of the A20YS/VV cell line failed 
to show constitutive association of unsheathed, YS-mutated receptors with CCVs (Figure 
3.9). This indicates that exposure of the transmembrane region alone is insufficient to induce 
the association of receptors with CCVs and that BCR destabilization does not simply expose 
a unique endocytosis motif. Another possible mechanism is that BCR-mediated signal 
transduction modifies the transmembrane tyrosine thereby dissociating Ig-α/Ig-β from μm. 
For this scenario, the transmembrane amino acids that are shielded by Ig-α/Ig-β (within the 
carboxy-terminal polar patch) must become exposed to cytoplasmic kinases. Others have 
suggested that antigen ligation of the BCR induces conformational changes within μm that 
displace μm into the cytoplasm or create a rotational torque on μm (1, 18). These 




Figure 3.9. Exposure of the transmembrane region of μm alone is insufficient to induce 
the association of receptors with CCVs. (Α)A20YS/VV cells were fixed prior to the 
preparation, and then stained with PC10BSA-gold (10 nm, arrow heads) and clathrin (5 nm, 
small arrows) or, (B) stimulated for 5 minutes prior to preparation and staining of native 
membranes. 
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BCR destabilization and the association of receptors with CCVs are dependent on the 
activation of the src-family kinase, Lyn (91, 116). Others have described that entry of antigen 
into CCVs involves the phosphorylation of clathrin heavy chain by Lyn (83). Our data 
indicate that despite normal Lyn phosphorylation (Figure 3.4), receptors failed to dissociate 
Ig-α/Ig-β from μm and failed to associate with CCVs. This suggests that clathrin heavy chain 
phosphorylation is not sufficient for entry of antigen-loaded μm into CCV. To assess if the 
normal Lyn activation in A20WT and A20Y/F cells induced clathrin heavy chain 
phosphorylation, we immunoprecipitated clathrin heavy chain and immunoblotted for 
phospho-tyrosine. We were unsuccessful in detecting clathrin phosphorylation in A20WT 
cells despite confirming that human B cells (Ramos) (83) show modest antigen-induced 
clathrin phosphorylation as previously reported (Figure 3.10). Collectively, we propose a 
model wherein antigen-induced signal transduction activates Lyn and possibly prepares 
CCVs for entry of antigen-bound receptors. Simultaneously, antigen-mediated signal 
transduction induces BCR destabilization and possibly modifies μm to facilitate entry of 
antigen-bound μm into CCVs. In the absence of destabilization, antigen-bound receptors do 
not enter the endocytic pathway as evidenced by the failure to detect antigen in the LAMP-1+ 
compartments and the failure to present antigens to T cells. In summary, the data indicate 
that CCV-mediated endocytosis is the predominant means of antigen entry into the endocytic 
pathway, and that BCR destabilization, and the association of receptors with CCVs are 




 Figure 3.10. Phosphorylation of clathrin heavy chain is undetectable in A20 cells. Cells 
were either unstimulated or stimulated with antigen (PC10BSA, 1μg/5x106 cells/ml, A20WT 
and A20Y/F cells) for 1 minute or anti-human μ antibody (10μg/5x106cells/ml, Ramos cells) 
for 1 minute.  Cells were lysed in 1% NP-40 buffer and whole cell lysates were 
immunoblotted for anti-phospho-tyrosine, or immunoprecipitated with anti-clathrin heavy 






Chapter IV. Conclusions 
At the core of the humoral immune response lie B cells that recognize soluble antigen 
through the BCR. Antigen binding is mediated by the antigen-recognition subunit, μ-heavy 
chain (μm) and the information of the antigen is transmitted into cells by phosphorylation of 
the ITAMs within the Ig-α/Ig-β signaling subunit, resulting in activation of multiple signal 
transduction cascades. Concurrently, antigen-bound receptors are internalized via CCVs and 
transported to the endosomal system. This allows antigen-receptor complexes to travel 
through the early and late endosomes, where protein antigen is cleaved into peptides by 
endosomal proteases. Although seemingly independent, the two functions of the BCR have 
been shown to be interrelated. Many effecter molecules found in the BCR signal transduction 
pathways also regulate endocytosis and trafficking of receptor-antigen complexes throughout 
the endosomal system. This cooperation culminates in the loading of antigen-derived 
peptides onto newly synthesized MHC class II complexes, promoting T cell help and the 
differentiation of B cells into antibody secreting cells.  
 
Many studies of BCR function have been based on two widely accepted views. First, the dual 
functions of BCR (signal transduction and antigen endocytosis) are thought to be mediated 
by an intact, stable BCR complex as it traffics from the cell surface to the endocytic pathway. 
Second, the ITAMs of Ig-α/Ig-β serve as an endocytic sorting motif for BCR as the ITAMs 
structurally mimic the canonical tyrosine-based sorting motif (YXXØ). However these views 
were challenged by two important observations. First, antigen stimulation induced the 
destabilization of the BCR complex, coincident with receptor desensitization. This raised the 
possibility that the destabilized BCR subunits may simultaneously facilitate antigen transport 
via μm and signal transduction via Ig-α/Ig-β. Second, activation of tyrosine-based sorting 
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motifs through phosphorylation inhibited the binding with the clathrin-adaptor molecule, AP-
2 complex. This argued against the idea that the activated Ig-α/Ig-β ITAMs serve as a sorting 
motif for the BCR. During the course of my thesis, my research remodeled our views on the 
trafficking of the BCR complex and its role in antigen processing. We elucidated the earliest 
events following receptor ligation, revealing a novel view of the BCR complex during signal 
transduction and endocytosis.  
 
Early studies showed that antigen ligation of the BCR induced receptor destabilization 
wherein decreased Ig-α/Ig-β coprecipitated with μm. This suggests that Ig-α/Ig-β may 
physically dissociate from μm, promoting independent movement to different subcellular 
locations. We now provided the first evidence that the BCR complex dissociated within 2 
minutes of receptor ligation and that the receptor subunits separated by greater than 180 nm. 
In addition, dissociated μm was found in CCVs in the absence of Ig-α/Ig-β while Ig-α/ Ig-β 
translocated into lipid rafts without expected stoichiometric amounts of μm and persisted in 
lipid rafts. These findings challenge the widely held view that an intact BCR complex 
translocates into lipid rafts and enters the endocytic pathway. Since the unsheathed μm 
internalizes via CCVs and Ig-α/Ig-β remained in lipid rafts on the cell surface, it is now 
necessary to consider each BCR subunit independently. This impacts much of the previous 
literature where tracking of μm in the late endosomes has been assumed to be the μm/Ig-
α/Ig-β complex (37, 40, 44, 53, 76-78, 81, 83, 84, 86, 100, 114, 117, 118). We propose a new 
model where antigen-bound μm quickly enters the endocytic pathway within 2 minutes to 
expedite antigen processing. In contrast, Ig-α/Ig-β persists in lipid rafts up to 30 minutes at 
high concentration, and remains up to 2 hours at approximately 2-fold lower concentration to 
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maintain the activation of key signaling molecules that are necessary for acidification of 
endosomal compartments and for guiding antigen-μm complexes into late endosomes. 
Prolonged residency of Ig-α/Ig-β in lipid rafts is possibly due to the intrinsic slow turnover 
rate of lipid rafts or the rapid recycling of Ig-α/Ig-β through the early endosomes. Although 
the majority of Ig-α/Ig-β stays on lipid rafts, some minor pools of Ig-α/Ig-β may enter the 
late endosomes with delayed kinetics, as some of the Ig-α was found in the late endosomes. 
In our model, the status of the BCR complex dictates the intracellular itinerary of receptors. 
We proposed that coupled BCR have a low affinity for both CCVs and lipid rafts, however 
they may internalize into early endosomes for recycling or move into lysosomes for 
degradation. Our data show that receptors that fail to dissociate are evident in intracellular 
compartments, however, they fail to colocalize with late endosomes. Failure to dissociate 
receptors also attenuates the phosphorylation of signaling effectors by 15-30 minutes 
following receptor ligation. This suggests that in the absence of BCR dissociation, receptors 
may move to a degradation pathway.  
 
Our findings that antigen is found in CCVs in the absence of Ig-α/Ig-β implies that the 
ITAMs do not play a role in antigen-driven endocytosis. This finding not only argues against 
the previous model wherein ITAMs of Ig-α/Ig-β direct association of the BCR with CCVs, 
but also provokes the idea that other non-canonical, novel endocytic motifs exist. Since 
unsheathed μm directly associates with CCVs, it likely contains such a motif. Interestingly, 
no canonical endocytic motif is found within the transmembrane region or cytoplasmic tail of 
μm. However, it is possible that antigen stimulation modifies these domains to unsheathe μm 
from Ig-α/Ig-β, revealing a non-canonical motif that either associates with the AP-2 complex, 
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or serves as a docking site for a chaperone to promote the association of μm with CCVs. 
Since ubiquitination has been discovered as a novel endocytic motif, it is tempting to 
speculate that the dual lysine residues in the cytoplasmic tail of μm may act as substrates for 
ubiquitination. Alternatively, the transmembrane region of μm may undergo conformational 
changes upon antigen stimulation, such that kinase-mediated phosphorylation in the 
transmembrane region increases its affinity for CCVs. Collectively, our findings demonstrate 
that antigen-bound μm is not simply guided by Ig-α/Ig-β to the endocytic pathway, but 
actively recruited by a novel mechanism. Ongoing investigations in the laboratory focus on 
establishing whether the transmembrane tyrosine is phosphorylated and what substrates bind 
this region, in an effort to identify this novel mechanism.  
 
To address the role of BCR dissociation in antigen processing, we analyzed the effects of 
blocking BCR dissociation on the association of receptors with CCVs, LAMP-1+ late 
endosomes, and antigen presentation. Under conditions where src-family kinases were 
inactivated, BCR dissociation was blocked and μm failed to associate with CCVs. In addition, 
a BCR mutant (Y587F) defective in antigen presentation was found to be unable to dissociate 
the receptor complex and enter the late endosomes. These findings support our hypothesis 
that BCR dissociation is required for targeting of antigen to CCVs at the level of the plasma 
membrane and for the downstream events including antigen processing and presentation. 
Thus, only destabilized BCRs participate in initiating immune responses. This shows that 
BCR dissociation is a necessary step for the targeting of antigen to the endocytic pathway. It 
remains unclear if blocking BCR destabilization impairs T-dependent immune responses in 
vivo. Our findings illustrate a linear progressive set of events following antigen stimulation, 
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initiated by BCR dissociation, antigen targeting to CCVs by μm, antigen processing in late 
endosomes, and antigen presentation. However, the role of lipid rafts in antigen processing is 
unclear. The possibility remains that BCR dissociation occurs in lipid rafts, and that μm-
antigen complexes internalize into late endosomes from lipid rafts via rafts-associated CCVs 
or lipid carriers. Thus, failure to dissociate the BCR in cells expressing Y587F receptors may 
cause an unexpected malfunction in the association of receptors with lipid rafts, in rafts-
associated molecules, such as Lyn or their attachment with cytoskeletons, thereby impairing 
antigen processing. However, others show that receptors harboring a Y587F mutation within 
the transmembrane region of μm translocate into lipid rafts following antigen stimulation 
comparably to non-mutated receptors. In addition, lipid rafts-associated Lyn remained 
functional in B cells that failed to process and present antigens. This suggests that blocking 
BCR dissociation by the Y587F mutation does not affect the association of receptors with 
lipid rafts or the activity of raft-associated kinases. Receptors expressed on the surface in the 
absence of Ig-α/Ig-β (Y587, S588/VV) are capable of binding the cytoskeleton, suggesting 
cytoskeletal attachment is independent of BCR-signals. Thus, it is unlikely that failure to 
dissociate the BCR impairs the cytoskeletal attachment of receptors. These argue that in the 
absence of BCR dissociation and the association of receptors with CCVs, lipid rafts cannot 
restore antigen processing.  
 
Receptor ligation by self-antigens renders B cells unresponsive to continued or renewed BCR 
signaling; a phenomenon termed ‘anergy’. While investigating whether BCR dissociation 
plays a role in maintaining tolerance was not the scope of this study, many studies support 
that this may be the case. BCR signaling was shown to be trans-modulated by destabilized 
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receptors in vitro. In many Ig transgenic models of B cell tolerance, B cells continue to bind 
self-antigens, yet exhibit a desensitized phenotype. Thus, it is tempting to speculate that 
chronic BCR ligation with self-antigen induces a constitutive dissociation of the receptor 
complex, reducing the cellular response. This model predicts that removal of self-antigen or 
blocking of antigen ligation will reverse the constitutive receptor dissociation and the BCR 
will regain its ability to transduce signals when bound by self-antigens, leading to breakdown 
of tolerance. Collectively, we present a unifying model wherein antigen stimulation induces 
BCR dissociation that initiates an immune response against most soluble protein antigens 
while maintaining tolerance against self-antigen.  
 
It is of great biological interest to identify the molecular basis of BCR destabilization. A 
BCR mutant that associates with Ig-α/Ig-β but is unable to dissociate would allow us to 
elucidate the role of destabilization in antigen presentation by MHC class II and in B cell 
tolerance. During the course of my thesis work, we found that the carboxy-terminal polar 
patch of μm mediates the dissociation of Ig-α/Ig-β from μm. We discovered that among the 
carboxy-terminal polar residues, tyrosine 587 of the μm transmembrane region is critical in 
facilitating BCR destabilization. Mutation of tyrosine to valine allowed association of the 
BCR complex, but as we discovered, failed to trigger receptor dissociation. How the 
transmembrane tyrosine of μm regulates dissociation of the BCR complex remains unknown. 
We believe that in resting B cells, the transmembrane tyrosine of μm is sheathed by the Ig-
α/Ig-β transmembrane region and is therefore embedded in the lipid bilayer of the plasma 
membrane. Since no enzymatic activity is associated with the transmembrane region of μm, 
we reasoned that antigen binding to the BCR may trigger conformational changes of μm such 
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as rotation or a pushing-down of the transmembrane region into the cytoplasm, exposing the 
transmembrane tyrosine to be modified and thereby dissociating Ig-α/Ig-β from μm. While 
there could be multiple scenarios that modify the transmembrane tyrosine, it is worthwhile to 
test the possibility that the phosphorylation of tyrosine-587 may reduce the interaction of μm 
with Ig-α/Ig-β. Since the transmembrane tyrosine of μm is also required for the association 
of μm with CCVs, modification of Y587 might trigger BCR destabilization and the 
association of μm with CCVs. Whether the transmembrane tyrosine is phosphorylated and 
directly recruits the endosomal machinery is being investigated.  
 
This study advanced our understandings of the functions of the BCR in immune response. 
Specifically, the early events of BCR-mediated signal transduction and antigen targeting is 
now proven to be dissected with each receptor subunit. Furthermore, the status of the BCR 
complex dictates the functionality of receptors. Finally, the identification of the site that 
regulates BCR dissociation expedites investigation of the molecular mechanisms of receptor 
dissociation and antigen targeting to the endocytic pathway.  
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